Buy in shop
, to see if you have full access to this publication.
Monograph No access

Aufholende Entwicklung in der globalen Ökonomie

Pharmazeutische Innovationssysteme in Indien und Brasilien
Authors:
Publisher:
 2015

Bibliographic data

Edition
1/2015
Copyright Year
2015
ISBN-Print
978-3-8487-2132-0
ISBN-Online
978-3-8452-6232-1
Publisher
Nomos, Baden-Baden
Series
Vergleichende Analyse politischer Systeme
Volume
6
Language
German
Pages
394
Product Type
Monograph

Table of contents

ChapterPages
  1. Titelei/Inhaltsverzeichnis No access 1 - 18
  2. Verzeichnis der Fallbeispiele No access 19 - 20
  3. Einleitung No access 21 - 31
  4. Die Globalisierung pharmazeutisch-technologischer Wissensgewinnung No access 32 - 65
  5. Theoretische Grundlagen: Governance von technologischer Wissensgewinnung No access 66 - 101
  6. Konzept und Methode No access 102 - 127
  7. Indien: Exportorientierte Innovationsförderung durch Markt-Governance No access 128 - 213
  8. Brasilien: Binnenorientierte Versorgungssicherheit durch Hierarchie No access 214 - 303
  9. Vergleich: Pharmazeutische Innovationssysteme in Indien und Brasilien No access 304 - 330
  10. Schlussbetrachtung No access 331 - 353
  11. Quellen- und Literaturverzeichnis No access 354 - 394

Bibliography (647)

  1. Rau, B. S. & P. V. Appaji (2012), Dynamics of Drug Master Filings at United States Food and Drug Administration, The Pharma Review,(May-June), 65-71. Open Google Scholar DOI: 10.5771/9783845262321
  2. Ravenhill, John (2014), Global value chains and development, Review of International Political Economy, 21(1), 264-274. Open Google Scholar DOI: 10.5771/9783845262321
  3. Reddy, Madhuri et al. (2007), Oral Drug Therapy for Multiple Neglected Tropical Diseases: A Systematic Review, JAMA - The Journal of the American Medical Association, 298(16), 1911-1924. Open Google Scholar DOI: 10.5771/9783845262321
  4. Reh, Werner (1995), Quellen- und Dokumentenanalyse in der Politikfeldforschung: Wer steuert die Verkehrspolitik?, in: Ulrich von Alemann et al. (Hrsg.), Politikwissenschaftliche Methoden: Grundriß für Studium und Forschung, Opladen: Westdeutscher Verlag, 201-260. Open Google Scholar DOI: 10.5771/9783845262321
  5. Reichman, Jerome H. (2002), From Free Riders to Fair Followers: Global Competition under the TRIPS Agreement, in: Ruth Towse & Rudi Holzhauer (Hrsg.), The Economics of Intellectual Property. Competition and International Trade, IV, Cheltenham: Edward Elgar, 446-527. Open Google Scholar DOI: 10.5771/9783845262321
  6. Reis, Carla, João Pieroni Pieroni & José Oswaldo Barros de Souza (2010), Biotecnologia para saúde no Brasil, BNDES Setorial, 32, 193-230. Open Google Scholar DOI: 10.5771/9783845262321
  7. Reis, Renata, Marcela Foçaça Vieira & Gabriela Costa Chaves (2009), Access to medicines and intellectual property in Brazil: A civil society perspective, in: Renata Reis et al. (Hrsg.), Intellectual Property Right and Access to ARV Medicines - Civil Society Resistance in the Global South, Rio de Janeiro: ABIA, 12-54. Open Google Scholar DOI: 10.5771/9783845262321
  8. Reuters (2012), Novartis argues for Glivec patent at India's top court, 11.09.12. Open Google Scholar DOI: 10.5771/9783845262321
  9. Rezaie, Rahim (2011), Health Technology Innovation by Indigenous Enterprises in China, India and Brazil, A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy, Toronto: University of Toronto, Institute of Medial Science. Open Google Scholar DOI: 10.5771/9783845262321
  10. Rezaie, Rahim et al. (2008), Brazilian health biotech - fostering crosstalk between public and private sectors, Nature Biotechnology, 26(6), 627 - 644. Open Google Scholar DOI: 10.5771/9783845262321
  11. Richards, Caroline (2011), BRIC: Pricing, Reimbursement, and Regulatory Update, London: Datamonitor. Open Google Scholar DOI: 10.5771/9783845262321
  12. Risse, Thomas & Ursula Lehmkuhl (2007), Regieren ohne Staat? Governance in Räumen begrenzter Staatlichkeit, Baden-Baden: Nomos. Open Google Scholar DOI: 10.5771/9783845262321
  13. Rodrik, Dani (1997), Has Globalization Gone Too Far?, Washington, D.C.: Institute for International Economics. Open Google Scholar DOI: 10.5771/9783845262321
  14. Roemer-Mahler, Anne (2013), Business conflict and global politics: The pharmaceutical industry and the global protection of intellectual property rights, Review of International Political Economy, 20(1), 121-152. Open Google Scholar DOI: 10.5771/9783845262321
  15. Rogers, Everett M. (2003), Diffusion of Innovations, New York: Free Press. Open Google Scholar DOI: 10.5771/9783845262321
  16. Romer, Paul Michael (1994), The Origins of Endogenous Growth, Journal of Economic Perspectives, 8(1), 3-22. Open Google Scholar DOI: 10.5771/9783845262321
  17. Rostow, Walt Whitman (1960), The Stages of Economic Growth: A Non-Communist Manifesto, Cambridge: Cambridge University Press. Open Google Scholar DOI: 10.5771/9783845262321
  18. Ryan, Michael P. (2010), Patent Incentives, Technology Markets, and Public–Private Bio-Medical Innovation Networks in Brazil, World Development, 38(8), 1082-1093. Open Google Scholar DOI: 10.5771/9783845262321
  19. Saha, Raghav (2012), National Study on Intellectual Property and Small and Medium Sized Enterprises: India, Geneva: World Intellectual Property Organization, September. Open Google Scholar DOI: 10.5771/9783845262321
  20. Salama, Bruno & Daniel Benoliel (2010), Pharmaceutical Patent Bargains: The Brazilian Experience, Cardozo Journal of International and Comparative Law 18, 633-682. Open Google Scholar DOI: 10.5771/9783845262321
  21. Sampath, Padmashree Gehl (2010), Economic Aspects of Access to Medicines after 2005: Product Patent Protection and Emerging Firm Strategies in the Indian Pharmaceutical Industry, Maastricht: United Nations University, Institute for New Technologies. Open Google Scholar DOI: 10.5771/9783845262321
  22. San Francisco Bay Guardian (2005), Balm of Gilead: Local activists back Brazil's demand that US companies allow the creation of cheap, generic AIDS drugs, 05.07.05. Open Google Scholar DOI: 10.5771/9783845262321
  23. Saraswathy, Beena (2006), Mergers and Acquisitions in the Indian Pharmaceutical Industry: Nature, Structure and Performance, MPRA Papers, No. 8144, Munich: University Library of Munich. Open Google Scholar DOI: 10.5771/9783845262321
  24. Sartori, Giovanni (1991), Comparing and Miscomparing, Journal of Theoretical Politics, 3(3), 243-257. Open Google Scholar DOI: 10.5771/9783845262321
  25. Sartori, Laura (2009), Consumption in Developing Nations, in: Salustiano del Campo (Hrsg.), Encyclopedia of Life Support Systems, VII, Oxford: EOLSS. Open Google Scholar DOI: 10.5771/9783845262321
  26. Saúde Web (2012), Padilha assina 20 parcerias para produção de medicamentos e vacinas, <http://saudeweb.com.br/33473/padilha-assina-20-parcerias-para- Open Google Scholar DOI: 10.5771/9783845262321
  27. producao-de-medicamentos-e-vacinas/>. Open Google Scholar DOI: 10.5771/9783845262321
  28. Scerri, Mario & Helena Lastres (2010), Comparative Report on the State and the National System of Innovation in BRICS, BRICS Project, Rio de Janeiro. Open Google Scholar DOI: 10.5771/9783845262321
  29. Scerri, Mario & Helena M. M. Lastres (Hrsg.) (2013a), The Role of the State, New Delhi: Routledge. Open Google Scholar DOI: 10.5771/9783845262321
  30. Scerri, Mario & Helena M. M. Lastres (2013b), The State and the Architecture of National Systems of Innovation, in: Mario Scerri & Helena M. M. Lastres (Hrsg.), The Role of the State, New Delhi: Routledge, 1-22. Open Google Scholar DOI: 10.5771/9783845262321
  31. Scharpf, Fritz W. (1997), Games Real Actors Play: Actor-Centered Institutionalism in Policy Research, Boulder: Westview Press. Open Google Scholar DOI: 10.5771/9783845262321
  32. Scharpf, Fritz W. (2000), Interaktionsformen: Akteurzentrierter Institutionalismus in der Politikforschung, Wiesbaden: VS Verlag für Sozialwissenschaften. Open Google Scholar DOI: 10.5771/9783845262321
  33. Schneider, Volker & Frank Janning (2006), Politikfeldanalyse: Akteure, Diskurse und Netzwerke in der öffentlichen Politik, Wiesbaden: VS Verlag für Sozialwissenschaften. Open Google Scholar DOI: 10.5771/9783845262321
  34. Schöne, Helmar (2005), Die teilnehmende Beobachtung als Datenerhebungsmethode in der Politikwissenschaft: Methodologische Reflexion und Werkstattbericht, Historical Social Research, 30(1), 168-199. Open Google Scholar DOI: 10.5771/9783845262321
  35. Schumacher, Christian (2012), CRAMS outsourcing in pharmaceutical and chemical research and manufacturing, part III, Science and Technology Blog, 03.09.12, <http://blog.stepchange-innovations.com/2012/09/crams-outsourc Open Google Scholar DOI: 10.5771/9783845262321
  36. ing-in-pharmaceutical-and-chemical-research-and-manufactu Open Google Scholar DOI: 10.5771/9783845262321
  37. ring-part-iii/#.UhONQ23TLW5>. Open Google Scholar DOI: 10.5771/9783845262321
  38. Schumpeter, Joseph (1934), The Theory of Economic Development: An Inquiry Into Profits, Capital, Credit, Interest, and the Business Cycle, Port Washington: Kennikat. Open Google Scholar DOI: 10.5771/9783845262321
  39. Seitz, Konrad (2000), Die neue Welt der Geo-Ökonomie: Das globale Ringen um die technologische Vorherrschaft, in: Karl Kaiser & Hans-Peter Schwarz (Hrsg.), Weltpolitik im neuen Jahrhundert, Baden-Baden: Nomos, 307-326. Open Google Scholar DOI: 10.5771/9783845262321
  40. Sell, Susan (1995), Intellectual Property Protection and Antitrust in the Developing World, International Organization, 49(2), 315-349. Open Google Scholar DOI: 10.5771/9783845262321
  41. Sell, Susan (2006), Intellectual Property and the Doha Development Agenda, Global Social Policy, 6(2), 147-150. Open Google Scholar DOI: 10.5771/9783845262321
  42. Sennes, Ricardo Ubiraci, Gabriel Kohlmann & Anselmo Takaki (2011), Os movimentos das multinacionais e a internacionalização da pesquisa, desenvolvimento e inovação, in: Ricardo Ubiraci Sennes & Antonio Britto Filho (Hrsg.), Inovações tecnológicas no Brasil, São Paulo: Cultura Acadêmica, 127-146. Open Google Scholar DOI: 10.5771/9783845262321
  43. Serra, Narcis & Joseph E. Stiglitz (Hrsg.) (2008), The Washington Consensus Reconsidered: Towards a New Global Governance, Oxford: Oxford University Press. Open Google Scholar DOI: 10.5771/9783845262321
  44. Shadlen, Kenneth C. (2007), The Political Economy of AIDS Treatment: Intellectual Property and the Transformation of Generic Supply, International Studies Quarterly, 51(3), 559-581. Open Google Scholar DOI: 10.5771/9783845262321
  45. Shadlen, Kenneth C. (2008), Revolution, Reform, and Reinforcement: Latin American Responses to the Globalization of Intellectual Property, ECPR Joint Sessions Workshop No. 14: "The Politics of Intellectual Property", Rennes, 11.-16. April. Open Google Scholar DOI: 10.5771/9783845262321
  46. Shadlen, Kenneth C. (2009a), The Political Contradictions of Incremental Innovation in Late Development: Lessons from Pharmaceutical Patent Examination in Brazil, American Political Science Association, 2009 Annual Meeting and Exhibition, Toronto, 03.-06. September. Open Google Scholar DOI: 10.5771/9783845262321
  47. Shadlen, Kenneth C. (2009b), Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies, Comparative Politics, 42(1), 41-58. Open Google Scholar DOI: 10.5771/9783845262321
  48. Shadlen, Kenneth C. (2013), The Patent Policy Trilemma, Journal für Entwicklungspolitik, 29(2), 87-104. Open Google Scholar DOI: 10.5771/9783845262321
  49. Shadlen, Kenneth C. (2011), The Political Contradictions of Incremental Innovation: Lessons from Pharmaceutical Patent Examination in Brazil, Politics & Society 39(2), 143-174. Open Google Scholar DOI: 10.5771/9783845262321
  50. Shankland, Ben (2008), Novartis Seeks to Form Partnerships with Health Providers in Brazil, Global Insight, 04.04.08. Open Google Scholar DOI: 10.5771/9783845262321
  51. Sharif, Naubahar (2006), Emergence and development of the National Innovation Systems concept, Research Policy, 35(5), 745-766. Open Google Scholar DOI: 10.5771/9783845262321
  52. Shaver, Lea (2010), Access to Knowledge in Brazil: New Research on Intellectual Property, Innovation and Development, Hofstra University School of Law Legal Studies Research Paper Series Research Paper 10-49 Open Google Scholar DOI: 10.5771/9783845262321
  53. Shiva, Vandana (2001), Protect or Plunder? Understanding Intellectual Property Rights, London: Zed Books. Open Google Scholar DOI: 10.5771/9783845262321
  54. Singh, Malvinder Mohan (2006), Will India Become the Global Centre for Pharmaceutical Research & Development?, Journal of Generic Medicines, 3(3), 194-200. Open Google Scholar DOI: 10.5771/9783845262321
  55. Sivaraman, R. (2012), Bayer plea against Natco on cancer drug dismissed, The Hindu, 16.09.12. Open Google Scholar DOI: 10.5771/9783845262321
  56. Skocpol, Theda & Margaret Somers (1980), The Uses of Comparative History in Macrosocial Inquiry, Comparative Studies in Society and History, 22(2), 174-197. Open Google Scholar DOI: 10.5771/9783845262321
  57. Sleeboom, Margaret (2003), Monitored Freedom: Party and Research Reforms at CASS, China Report, 39(2), 213-227. Open Google Scholar DOI: 10.5771/9783845262321
  58. Solingen, Etel (1996), Industrial policy, technology, and international bargaining: design-ing nuclear industries in Argentina and Brazil, Stanford: Stanford University Press. Open Google Scholar DOI: 10.5771/9783845262321
  59. Spicy IP (2008), Roche vs NATCO: India's First "Doha Style" Compulsory License?, 16.01.08. Open Google Scholar DOI: 10.5771/9783845262321
  60. Spicy IP (2010a), Breaking News: Matrix Restrained from Infringing Roche’s Cancer Patent, 19.09.10. Open Google Scholar DOI: 10.5771/9783845262321
  61. Spicy IP (2010b), DIPP Discussion Paper on Compulsory Licensing in the Indian Pharmaceutical Sector: An 'Acquired' Afterthought?, 25.08.10. Open Google Scholar DOI: 10.5771/9783845262321
  62. Spicy IP (2010c), DIPP receives diverse replies to its CL discussion paper, 08.10.10. Open Google Scholar DOI: 10.5771/9783845262321
  63. Spicy IP (2010d), Guest Post: Requiem for a Dream?, 30.08.10. Open Google Scholar DOI: 10.5771/9783845262321
  64. Spicy IP (2010e), Indian "Bayh Dole" and a Painful End to the Pursuit of Pleasure, 10.08.10. Open Google Scholar DOI: 10.5771/9783845262321
  65. Spicy IP (2010f), Indian IP Policy Formulation: From Confusion to Coherence, 22.03.10. Open Google Scholar DOI: 10.5771/9783845262321
  66. Spicy IP (2010g), An overview of the 'Health Impact Fund' model for accessible medicines, 06.07.10. Open Google Scholar DOI: 10.5771/9783845262321
  67. Spicy IP (2010h), Roche-Natco update: "Public interest" again?, 17.05.10. Open Google Scholar DOI: 10.5771/9783845262321
  68. Spicy IP (2010i), Roche-Natco update: Natco commences arguments, 28.06.10. Open Google Scholar DOI: 10.5771/9783845262321
  69. Spicy IP (2010j), Roche-Natco update: Roche concludes arguments, 30.05.10. Open Google Scholar DOI: 10.5771/9783845262321
  70. Spicy IP (2011a), CIPLA files for a compulsory license against Merck's Isentress, 06.04.11. Open Google Scholar DOI: 10.5771/9783845262321
  71. Spicy IP (2011b), Debating the legality and the efficacy of the CSIR-Patent Office agreement to out-source prior art searches, 18.12.11. Open Google Scholar DOI: 10.5771/9783845262321
  72. Spicy IP (2011c), Natco seeks license from Pfizer to manufacture a low-cost version of HIV drug, 06.01.11. Open Google Scholar DOI: 10.5771/9783845262321
  73. Spicy IP (2011d), A Small Step for Natco, a Giant Leap for Generic Drugs: India’s first Compulsory Licensing Application Filed, 05.08.11. Open Google Scholar DOI: 10.5771/9783845262321
  74. Spicy IP (2012a), Breaking news: Cipla succeeds in revoking Pfizer / Sugen's patent on Sunitinib, 03.10.12. Open Google Scholar DOI: 10.5771/9783845262321
  75. Spicy IP (2012b), Breaking News: India's First Compulsory License Granted!, 12.03.12. Open Google Scholar DOI: 10.5771/9783845262321
  76. Spicy IP (2012c), CSIR provides misleading information; aims to hide revenues from patent licensin, 22.09.12. Open Google Scholar DOI: 10.5771/9783845262321
  77. Spicy IP (2012d), CSIR pulls a fast one – does a U-Turn on disclosure of royalties earned through patent licensing, 13.09.12. Open Google Scholar DOI: 10.5771/9783845262321
  78. Spicy IP (2012e), Guest Post: Pharma patent developments in 2012 - A review, 31.12.12. Open Google Scholar DOI: 10.5771/9783845262321
  79. Spicy IP (2012f), National Science Day – The good and bad of Indian policy initiatives for scientific research and innovation, 27.02.12. Open Google Scholar DOI: 10.5771/9783845262321
  80. Spicy IP (2012g), Part I: IPCheckups & Intellectual Ventures: What are they about?, 12.11.12. Open Google Scholar DOI: 10.5771/9783845262321
  81. Spicy IP (2012h), Royalty Payment by Subsidiaries: Bane of Minority Investors?, 23.12.12. Open Google Scholar DOI: 10.5771/9783845262321
  82. Spicy IP (2012i), Why is it so difficult for CSIR to be ‘transparent’?, 07.04.12. Open Google Scholar DOI: 10.5771/9783845262321
  83. Spicy IP (2013a), The BDR compulsory licensing application and the BMS ‘Statements of Working’, 22.08.13. Open Google Scholar DOI: 10.5771/9783845262321
  84. Spicy IP (2013b), Breaking News: Second Compulsory Licensing Application Filed, 17.03.13. Open Google Scholar DOI: 10.5771/9783845262321
  85. Spicy IP (2013c), The Dasatinib compulsory license conundrum, 16.09.13. Open Google Scholar DOI: 10.5771/9783845262321
  86. Spicy IP (2013d), DIPP to issue CLs for Herceptin, Dastinib & Ixabepilone – End of the line for Big Pharma’s patents in the Indian market?, 12.01.13. Open Google Scholar DOI: 10.5771/9783845262321
  87. Spicy IP (2013e), The ‘Emcure model’ of Foreign Investment and Joint-Ventures, 31.01.13. Open Google Scholar DOI: 10.5771/9783845262321
  88. Spicy IP (2013f), Negotiating licenses between patent holders and generic producers: the Medicines Patent Pool, 28.06.13. Open Google Scholar DOI: 10.5771/9783845262321
  89. Spicy IP (2013g), Patent Ambush: Big Pharma vs Generics, 25.01.13. Open Google Scholar DOI: 10.5771/9783845262321
  90. Spicy IP (2013h), Patent war intensifies: Glenmark launches generic version of Merck’s Januvia, 02.04.13. Open Google Scholar DOI: 10.5771/9783845262321
  91. Spicy IP (2013i), The Royalty Payment Siphon by MNCs - Independent Director and Minority Voting as Possible Solutions?, 09.01.13. Open Google Scholar DOI: 10.5771/9783845262321
  92. Spicy IP (2013j), SpicyIP Events: FMC-DSIR-APTDC Workshop for Identifying the Technologies for Acquisition, 13.06.13. Open Google Scholar DOI: 10.5771/9783845262321
  93. Spicy IP (2013k), Why aren’t there any takers for compulsory licenses?, 12.02.13. Open Google Scholar DOI: 10.5771/9783845262321
  94. Srholec, Martin (2011), A multilevel analysis of innovation in developing countries, Industrial and Corporate Change, 20(6), 1539-1569. Open Google Scholar DOI: 10.5771/9783845262321
  95. Srinivasan, Sandhya (2009), The Clinical Trials Scenario in India, Economic & Political Weekly, 44(35). Open Google Scholar DOI: 10.5771/9783845262321
  96. Steffen Guise, Mônica & Adelina de Oliveira Novaes (2011), Balancing Health and Wealth: The Case of Patents and Access to Medicines in Brazil. Open Google Scholar DOI: 10.5771/9783845262321
  97. Stewart, Frances (1977), Technology and Underdevelopment, London: Macmillan. Open Google Scholar DOI: 10.5771/9783845262321
  98. Stewart, Frances (1984), Facilitating Indigenous Technical Change in Third World Countries, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London: Macmillan, 81-94. Open Google Scholar DOI: 10.5771/9783845262321
  99. Sundar, Mahesh (2013), Glenmark's Unique Indian Approach to successful NCE Research, <http://www.maheshsundar.com/Home/recent-developments-views-opin Open Google Scholar DOI: 10.5771/9783845262321
  100. ions-in-pharma-archives/glenmark-s-unique-indian-approach-to-success Open Google Scholar DOI: 10.5771/9783845262321
  101. ful-nce-research>. Open Google Scholar DOI: 10.5771/9783845262321
  102. Sweet, Cassandra M. (2007), Regulating the Tigers: The Institutional Dynamics of Indo-Brazilian Trade Reflections from the Pharmaceutical Sector, ELSNIT Conference, Institutional Dimensions of Integration and Trade, Barcelona, 01. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  103. Tachinardi, Maria Helena (1993), A Guerra Das Patentes: O conflito Brasil x EUA sobre propriedade intelectual, Sao Paulo: Paz e Terra. Open Google Scholar DOI: 10.5771/9783845262321
  104. TB Alliance (2013), TB Alliance Licenses Late-stage TB Program to CSIR-OSDD, 20.03.13, <http://www.tballiance.org/newscenter/view-brief.php?id=1076>. Open Google Scholar DOI: 10.5771/9783845262321
  105. Thach, Sharon & Susan J. Marsnik (2009), Patent Standards under TRIPS and the Pharmaceutical Industries in Brazil and India, Latin American Business Review, 10(4), 237-261. Open Google Scholar DOI: 10.5771/9783845262321
  106. The Indian Express (2011), Lupin inks pact with Brazil for TB drug supply, 05.01.11. Open Google Scholar DOI: 10.5771/9783845262321
  107. The Indian Express (2013a), CCI rules out case against US-based pharmaceutical, Gilead Sciences, 12.03.13. Open Google Scholar DOI: 10.5771/9783845262321
  108. The Indian Express (2013b), Govt moves to make three key cancer drugs cheaper, 12.01.13. Open Google Scholar DOI: 10.5771/9783845262321
  109. The Observatory (2010), The Observatory of Economic Complexity, Massachusetts Institute of Technology, <http://atlas.media.mit.edu/>. Open Google Scholar DOI: 10.5771/9783845262321
  110. ThePharmaLetter (2001), Wockhardt acquires all Rhein Biotech JV, 11.09.01. Open Google Scholar DOI: 10.5771/9783845262321
  111. ThePharmaLetter (2005), Wockhardt sets up JVs in Latin America and South Africa, 21.02.05. Open Google Scholar DOI: 10.5771/9783845262321
  112. Thorelli, Hans B. (1986), Networks: Between Markets and Hierarchies, Strategic Management Journal, 7(1), 37-51. Open Google Scholar DOI: 10.5771/9783845262321
  113. Thorsteinsdóttir, Halla et al. (2004a), Conclusions: Promoting Biotechnology Innovation in Developing Countries, Nature Biotechnology, 22 (12s), DC48-DC52. Open Google Scholar DOI: 10.5771/9783845262321
  114. Thorsteinsdóttir, Halla et al. (2004b), Introduction: Promoting Global Health Through Biotechnology, Nature Biotechnology, 22(12s), DC3-DC7. Open Google Scholar DOI: 10.5771/9783845262321
  115. Times of India (2004), Novartis licences Torrent's AGE breaker molecule, 30.07.04. Open Google Scholar DOI: 10.5771/9783845262321
  116. Times of India (2010), Govt may limit FDI in pharma sector at 49%, 06.09.10. Open Google Scholar DOI: 10.5771/9783845262321
  117. Times of India (2012), PMO push for free drugs at govt hospitals, 13.02.12. Open Google Scholar DOI: 10.5771/9783845262321
  118. Times of India (2013), Medicines Patent Pool and Roche tie up to increase access of key HIV drug, 05.08.13. Open Google Scholar DOI: 10.5771/9783845262321
  119. Timmermans, Karin & Togi Hutadjulu (2000), Report, ASEAN Workshop on the TRIPs Agreement and its Impact on Pharmaceuticals, Jakarta, 02.-04. Mai. Open Google Scholar DOI: 10.5771/9783845262321
  120. Truffer, Bernhard, Harald Rohracher & Jochen Markard (2009), The Analysis of Institutions in Technological Innovation Systems - A Conceptual Framework Applied to Biogas Development in Austria, DRUID Summer Conference 2009, Copenhagen, 16.-20. Juni. Open Google Scholar DOI: 10.5771/9783845262321
  121. Tyfield, David (2008), Enabling TRIPs: The pharma-biotech-university patent coalition, Review of International Political Economy, 15(4), 535-566. Open Google Scholar DOI: 10.5771/9783845262321
  122. U.S. PIRG & Community Catalyst (2013), Top Twenty Pay-for-delay Drugs: How Drug Industry Payoffs Delay Generics, Inflate Prices and Hurt Consumers, July 2013. Open Google Scholar DOI: 10.5771/9783845262321
  123. UN (2012), The Millennium Development Goals Report 2012, New York: United Nations. Open Google Scholar DOI: 10.5771/9783845262321
  124. UNAIDS (2012), UNAIDS Report on the global AIDS epidemic, Geneva: Joint United Nations Programme on HIV/AIDS. Open Google Scholar DOI: 10.5771/9783845262321
  125. UNESCO (2010), UNESCO Science Report 2010: The Current Status of Science around the World, Paris. Open Google Scholar DOI: 10.5771/9783845262321
  126. Urias, Eduardo & João Furtado (2009), Institutional changes and their impacts on the Brazilian Pharmaceutical Industry: Is there an Innovation System on the way?, 7th GLOBELICS International Conference: Inclusive Growth, Innovation and Technological Change: education, social capital and sustainable development, Dakar, 06.-08. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  127. Van Dyck, Pooja (2007), Importing Western Style, Exporting Tragedy: Changes in Indian Patent Law and Their Impact on AIDS Treatment in Africa, North Western Journal of Technology and Intellectual Property, 6(1), 138-151. Open Google Scholar DOI: 10.5771/9783845262321
  128. Veembur, Arun (2004), CRO: Boom Time for India, Siliconindia,(June), 50-52. Open Google Scholar DOI: 10.5771/9783845262321
  129. Veloso, Francisco & Jorge Mario Soto (2001), Incentives, Infrastructure and Institutions: Perspectives on Industrialization and Technical Change in Late-Developing Nations, Technological Forecasting and Social Change, 66, 87-109. Open Google Scholar DOI: 10.5771/9783845262321
  130. Vieira, Fabiola Sulpino (2009), Ministry of Health's depending on drugs: program trends from 2002-2007, Revista de Saúde Pública, 43(4), 206-209. Open Google Scholar DOI: 10.5771/9783845262321
  131. Viotti, Eduardo B. (2002), National Learning Systems - A new approach on technological change in late industrializing economies and evidences from the cases of Brazil and South Korea, Technological Forecasting & Social Change, 69, 653-680. Open Google Scholar DOI: 10.5771/9783845262321
  132. von Alemann, Ulrich & Wolfgang Tönnesmann (1995), Grundriß: Methoden in der Politikwissenschaft, in: Ulrich von Alemann (Hrsg.), Politikwissenschaftliche Methoden: Grundriss für Studium und Forschung, Opladen: Westdeutscher Verlag, 17-140. Open Google Scholar DOI: 10.5771/9783845262321
  133. Wade, Robert (2003), What strategies are viable for developing countries today? The World Trade Organization and the shrinking of ‘development space’, Review of International Political Economy, 10(4), 621-644. Open Google Scholar DOI: 10.5771/9783845262321
  134. Walgenbach, Peter & Renate Meyer (2008), Neoinstitutionalistische Organisationstheorie, Suttgart: Kohlhammer. Open Google Scholar DOI: 10.5771/9783845262321
  135. Waning, Brenda, Ellen Diedrichsen & Suerie Moon (2010), A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries, Journal of the International AIDS Society, 13(35). Open Google Scholar DOI: 10.5771/9783845262321
  136. Westphal, Larry E., W. Rhee Yung & Garry Pursell (1984), Sources of Technological Capability in South Korea, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London & Basingstoke: Macmillan, 279-300. Open Google Scholar DOI: 10.5771/9783845262321
  137. Wharton (2012), Sparring Over Sorafenib: How Will Natco’s Move against Bayer Affect Pharma Licensing?, Philadelphia: Knowledge@Wharton, The Wharton School, University of Pennsylvania, 19.04.12. Open Google Scholar DOI: 10.5771/9783845262321
  138. Whitley, Richard (2000), Divergent Capitalisms: The Social Structuring and Change of Business Systems, Oxford: Oxford University Press. Open Google Scholar DOI: 10.5771/9783845262321
  139. WHO (2002), The Selection of Essential Medicines, WHO Policy Perspectives on Medicines, No. 4, Juni. Open Google Scholar DOI: 10.5771/9783845262321
  140. WHO (2003), New initiative to research and develop drugs for the world’s most neglected diseases, Delhi: World Health Organization, 25.06.03, <http://www. Open Google Scholar DOI: 10.5771/9783845262321
  141. who.int/mediacentre/news/releases/2003/pr51/en/#>. Open Google Scholar DOI: 10.5771/9783845262321
  142. WHO (2004a), Equitable access to essential medicines: a framework for collective action, WHO Policy Perspectives on Medicines, No. 8, Juni. Open Google Scholar DOI: 10.5771/9783845262321
  143. WHO (2004b), The World Medicines Situation, Geneva. Open Google Scholar DOI: 10.5771/9783845262321
  144. WHO (2011), Noncommunicable diseases, Fact sheet, Geneva, March 2013, <http://www.who.int/mediacentre/factsheets/fs355/en/#>. Open Google Scholar DOI: 10.5771/9783845262321
  145. WHO (2012), Defining Disease Types I, II AND III, Background document provided by the WHO Secretariat, Geneva: WHO Secretariat. Open Google Scholar DOI: 10.5771/9783845262321
  146. WHO (2013), World Health Statistics 2013, Geneva: WHO Press. Open Google Scholar DOI: 10.5771/9783845262321
  147. WHO, WIPO & WTO (2012), Promoting Access to Medical Technologies and Innovation: Intersections between public health, intellectual property and trade, Geneva: World Health Organization, World Intellectual Property Organization and World Trade Organization. Open Google Scholar DOI: 10.5771/9783845262321
  148. Williamson, John (1989), What Washington Means by Policy Reform, in: John Williamson (Hrsg.), Latin American Adjustment: how much has happended?, Washington, D.C.: Institute for International Economics. Open Google Scholar DOI: 10.5771/9783845262321
  149. WIPO (2011), World Intellectual Property Report: The Changing Face of Innovation, WIPO Economics & Statistics Series, Geneva: World Intellectual Property Organization. Open Google Scholar DOI: 10.5771/9783845262321
  150. World Bank (2002), World Development Report 2002: Building Institutions for Markets, New York: Oxford University Press. Open Google Scholar DOI: 10.5771/9783845262321
  151. World Bank (2009), World Development Report 2009: Reshaping Economic Geography, Washington, D.C.: The World Bank. Open Google Scholar DOI: 10.5771/9783845262321
  152. World Bank (2010), Investing Across Borders 2010: Indicators of foreign direct investment regulation in 87 countries, Washington, D.C.: The World Bank Group. Open Google Scholar DOI: 10.5771/9783845262321
  153. Wright, Alan (2008), Innovation in Brazil: Public Policies and Business Strategies, March 2008, Washington, D.C.: Woodrow Wilson Center for Scholars, Brazil Institute and the Program on Science, Technology, America and The Global Economy. Open Google Scholar DOI: 10.5771/9783845262321
  154. Yeats, Alexander J. (2001), Just How Big is Global Production Sharing?, in: Sven W. Arndt & Henryk Kierzkowski (Hrsg.), Fragmentation: new production patterns in the world economy, Oxford: Oxford University Press, 108-143. Open Google Scholar DOI: 10.5771/9783845262321
  155. Young, Terry A. (2010), The Rise of Intellectual Property and Incubation in India, Beyond the First World, 1(8). Open Google Scholar DOI: 10.5771/9783845262321
  156. Zanatta, Mariana et al. (2008), National policies to attract FDI in R&D: An assessment of Brazil and selected countries, Research Paper, No. 69, Helsinki: United Nations University, World Institute for Development Economic Research . Open Google Scholar DOI: 10.5771/9783845262321
  157. Abbott, Frederick M. (2005), The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health, American Journal of International Law, 99(2), 317-358. Open Google Scholar DOI: 10.5771/9783845262321
  158. Abramovitz, Moses (1986), Catching Up, Forging Ahead, and Falling Behind, Journal of Economic History, 46(2), 385-406. Open Google Scholar DOI: 10.5771/9783845262321
  159. Abrol, Dinesh (2004), Post-TRIPS Technological Behaviour of the Pharmaceutical Industry in India, Science, Technology & Society, 9(2), 243-271. Open Google Scholar DOI: 10.5771/9783845262321
  160. Abrol, Dinesh, Pramod Prajapati & Nidhi Singh (2010), Globalization of the Indian pharmaceutical industry: Implications for the direction, distribution and diversity in drug innovation, 8th GLOBELICS International Conference: Making Innovation Work for Society - Linking, Leveraging and Learning, Kuala Lumpur, 01.-03. November. Open Google Scholar DOI: 10.5771/9783845262321
  161. Abrol, Dinesh, Pramod Prajapati & Nidhi Singh (2011), Globalization of the Indian Pharmaceutical Industry: Implications for Innovation, International Journal of Institutions and Economies, 3(2), 327-365. Open Google Scholar DOI: 10.5771/9783845262321
  162. Abromeit, Heidrun & Michael Stoiber (2006), Demokratien im Vergleich: Einführung in die vergleichende Analyse politischer Systeme, Wiesbaden: VS Verlag für Sozialwissenschaften. Open Google Scholar DOI: 10.5771/9783845262321
  163. Adeoti, John Olatunji (2002), Building technological capability in the less developed countries: the role of a national system of innovation, Science and Public Policy, 29(2), 95-104. Open Google Scholar DOI: 10.5771/9783845262321
  164. Adler, Emanuel (1988), State Institutions, Ideology, and Autonomous Technological Development: Computers and Nuclear Energy in Argentina and Brazil, Latin American Research Review, 23(2), 59-90. Open Google Scholar DOI: 10.5771/9783845262321
  165. Agência Saúde (2011), Saúde Não Tem Preço: Acesso a medicamentos gratuitos triplica no país, Ministério da Saúde, 13.09.2011. Open Google Scholar DOI: 10.5771/9783845262321
  166. Agência Saúde (2013), Ministério da Saúde vai investir R$ 35 bi até 2016 na compra de medicamentos produzidos no País, 23. April, <http://portalsaude.saude.gov.br/portalsaude/impressao/10405/162/ministerio-da-saude-vai-investir-r$-35-bi-ate-2016.html>. Open Google Scholar DOI: 10.5771/9783845262321
  167. Aggarwal, Aradhna (2004), Strategic Approach to Strengthening the International Competitiveness in Knowledge Based Industries: The Indian Pharmaceutical Industry, RIS Discussion Paper, 80/2004, New Delhi: Research and Information System for the Non-Aligned and Other Developing Countries. Open Google Scholar DOI: 10.5771/9783845262321
  168. Aggarwal, Aradhna (2006), Liberalisation, Technology Policies and Acquisition of Technological Capabilities: A Study of Indian Industry, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  169. AGU (2010), Parecer No. 337 /PGF/EA/2010, Brasília: Advocacia-Geral da União Procuradoria-Geral Federal, 04. März. Open Google Scholar DOI: 10.5771/9783845262321
  170. Alger, Jackeline et al. (2009), National health research systems in Latin America: a 14-country review, Pan American Journal of Public Health, 26(5), 447-457. Open Google Scholar DOI: 10.5771/9783845262321
  171. Altenburg, Tilman (2006), Governance Patterns in Value Chains and their Development Impact, The European Journal of Development Research, 18(4), 498-521. Open Google Scholar DOI: 10.5771/9783845262321
  172. Altenburg, Tilman (2009), Building inclusive innovation systems in developing countries: challenges for IS research, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 33-56. Open Google Scholar DOI: 10.5771/9783845262321
  173. Amable, Bruno (2000), Institutional Complementarity and Diversity of Social Systems of Innovation and Production, Review of International Political Economy, 7(4), 645-687. Open Google Scholar DOI: 10.5771/9783845262321
  174. Amann, Edmund (2000), Economic Liberalization and Industrial Performance in Brazil, Oxford: Oxford University Press. Open Google Scholar DOI: 10.5771/9783845262321
  175. Amighini, Alessia (2006), Upgrading in International Trade: Methods and Evidence from Selected Sectors in Latin America, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 221-250. Open Google Scholar DOI: 10.5771/9783845262321
  176. Amin, Tahir (2007), Voluntary Licensing Practices in the Pharmaceutical Sector: An Acceptable Solution to Improving Access to Affordable Medicines?, Initiative For Medicines, Access & Knowledge, 08.02.07. Open Google Scholar DOI: 10.5771/9783845262321
  177. Amsden, Alice H. (1989), Asia’s Next Giant: South Korea and Late Industrialization, Oxford: Oxford University Press. Open Google Scholar DOI: 10.5771/9783845262321
  178. Anderson, Warwick H. (2002), Postcolonial technoscience, Social Studies of Science, 32(5-6), 643-658. Open Google Scholar DOI: 10.5771/9783845262321
  179. AnproTec (2008), Portfolio de Parques Tecnológicos no Brasil, Brasília: Associação Nacional de Entidades Promotoras de Empreendimentos Inovadores, Dezember 2008. Open Google Scholar DOI: 10.5771/9783845262321
  180. Årdal, Christine (2012), Open Source Drug Discovery in Practice: A Case Study, PLOS Neglected Tropical Diseases, 6(9), 1-11. Open Google Scholar DOI: 10.5771/9783845262321
  181. Arndt, Sven W. & Henryk Kierzkowski (2001), Introduction, in: Sven W. Arndt & Henryk Kierzkowski (Hrsg.), Fragmentation: new production patterns in the world economy, Oxford: Oxford University Press, 1-16. Open Google Scholar DOI: 10.5771/9783845262321
  182. Arocena, Rodrigo & Judith Sutz (2000), Looking at National Systems of Innovation from the South, Industry and Innovation, 7(1), 55-75. Open Google Scholar DOI: 10.5771/9783845262321
  183. Asheim, Bjorn (2007), Differentiated Knowledge Bases and Varieties of Regional Innovation Systems, Innovation: The European Journal of Social Science Research, 20(3), 223-241. Open Google Scholar DOI: 10.5771/9783845262321
  184. Ashford, Nicholas A. & Ralph P. Hall (2011), Technology, Globalization, and Sustainable Development: Transforming the Industrial State, New Haven: Yale University Press. Open Google Scholar DOI: 10.5771/9783845262321
  185. ATX-BA (2012), A ATX-BA Parabeniza a Bahiafarma e a Novartis Pela Iniciativa em Prol Dos Pacientes Transplantados, <http://atxbahia.blogspot.de/2012/12/ Open Google Scholar DOI: 10.5771/9783845262321
  186. a-atx-ba-parabeniza-bahiafarma-e.html>. Open Google Scholar DOI: 10.5771/9783845262321
  187. Avila, Jorge (2008), Patentes Farmacêuticas no Brasil, 2° Encontro Nacional de Inovação em Fármacos e Medicamentos, Sao Paolo, 12.-13. November. Open Google Scholar DOI: 10.5771/9783845262321
  188. Ayyaswamy, Jancy, Neeraj Saxena & Antaryami Parida (2010), Government mediated program on intensifying industry- academia linkages for human resource development; Experiences of an innovative model from TIFAC, Forecasting & Assessment Council (TIFAC) Technology Information. Open Google Scholar DOI: 10.5771/9783845262321
  189. Bae, Zong-Tae & Jin-woo Chung (2001), The Impact of External Environment and Technological Learning System on the Relationship Between Technological Alliance and Performance of Korean Small Telecom Firms, Portland International Conference on Management of Engineering and Technology, Portland, 29.07.-02.08. Open Google Scholar DOI: 10.5771/9783845262321
  190. Bakhru, Girish & Nam Park (2013), India Pharmaceuticals: Generics are evolving, Mumbai: HSBC Global Research, Juni 2013. Open Google Scholar DOI: 10.5771/9783845262321
  191. Baković, Tomislav (2010), Managing innovation systems in transition economies, FEB-Zg working papers, 10-01, Zagreb: Faculty of Economics and Business, The University of Zagreb. Open Google Scholar DOI: 10.5771/9783845262321
  192. Balzat, Markus & Horst Hanusch (2004), Recent Trends in the Research on National Innovation Systems, Journal of Evolutionary Economics, 14(2), 197-210. Open Google Scholar DOI: 10.5771/9783845262321
  193. Barton, John et al. (2002), Integrating Intellectual Property Rights and Development Policy, Report of the Commission on Intellectual Property Rights, London: Commission on Intellectual Property Rights. Open Google Scholar DOI: 10.5771/9783845262321
  194. Basant, Rakesh (2006), Intellectual Property Rights Regime and Creation of Innovation based Enterprises in India, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  195. Baskaran, Angathevar & Rebecca Boden (2006), Knowledge Capital and Globalisation: Towards a new Conceptual Model, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  196. Bassala, George (1967), The Spread of Western Science, Science, 156(3775), 611-622. Open Google Scholar DOI: 10.5771/9783845262321
  197. Bastos, Maria Ines (1994), How international sanctions worked: Domestic and foreign political constraints on the Brazilian informatics policy, Journal of Development Studies, 30(2), 380-404. Open Google Scholar DOI: 10.5771/9783845262321
  198. Bastos, Valéria Delgado (2005), Inovação Farmacêutica: Padrão Setorial e Perspectivas para o Caso Brasileiro, BNDES Setorial, 22, 271-296. Open Google Scholar DOI: 10.5771/9783845262321
  199. Bazan, Luiza & Lizbeth Navas-Aleman (2004), The underground revolution in the Sinos Valley: a comparison of upgrading in global and national value chains, in: Hubert Schmitz (Hrsg.), Local Enterprises in the Global Economy: issues of governance and upgrading Cheltenham: Edward Elgar, 110-139. Open Google Scholar DOI: 10.5771/9783845262321
  200. BBC News (2004), Brazil to break Aids drug patents, 01.12.04. Open Google Scholar DOI: 10.5771/9783845262321
  201. Bell, Martin (1984), 'Learning' and the Accumulation of Industrial Technological Capacity in Developing Countries, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London: Macmillan, 187-209. Open Google Scholar DOI: 10.5771/9783845262321
  202. Bell, Martin & Keith Pavitt (1993), Technological Accumulation and Industrial Growth: Contrasts Between Developed and Developing Countries, Industrial and Corporate Change, 2(2), 157-210. Open Google Scholar DOI: 10.5771/9783845262321
  203. Bessen, James & Michael Meurer (2008), Patent Failure: How Judges, Bureaucrats, and Lawyers Put Innovators at Risk, Princeton: Princeton University Press. Open Google Scholar DOI: 10.5771/9783845262321
  204. Bhardwaj, Anshu, Vinod Scaria & Deblina Patra (2011), Open Source Drug Discovery: A Global Collaborative Drug Discovery Model for Tuberculosis, Science and Culture, 77(1-2), 22-26. Open Google Scholar DOI: 10.5771/9783845262321
  205. Bhattacharya, Radhika (2008), Are Developing Countries Going Too Far on Trips? A Closer Look at The new Laws in India, American Journal of Law and Medicine, 34(2-3), 395-421. Open Google Scholar DOI: 10.5771/9783845262321
  206. Bhattacharya, Sujit (2006), Harmonization of Patent Rules and Regulations and its Plausible Implications in Developing Countries: A Case Study of India, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  207. Bhojwani, Hiro (2005), Developing Innovative Capacity in India to Meet Health Needs, in: Ingrid Hering (Hrsg.), Innovation in Developing Countries to Meet Health Needs: Experiences of China, Brazil, South Africa and India, Oxford: The Centre for Management of IP in Health R&D, 112-153. Open Google Scholar DOI: 10.5771/9783845262321
  208. Bianchi Pagola, Carlos F. (2012), O papel das políticas públicas no regime de inovação de biotecnologia para saúde humana: Brasil 2002-2010, Tese de Doutorado, Rio de Janeiro: Instituto de Economia da Universidade Federal do Rio de Janeiro. Open Google Scholar DOI: 10.5771/9783845262321
  209. Bidwai, Praful (1995), One Step Forward, Many Steps Back: Dismemberment of India’s National Drug Policy, Development Dialogue, 1995(1), 193-222. Open Google Scholar DOI: 10.5771/9783845262321
  210. Bierly, P.E. III & A.K. Chakrabarti (1996), Technological learning, strategic flexibility, and new product development in the pharmaceutical industry, IEEE Transactions on Engineering Management, 43(4), 368-380. Open Google Scholar DOI: 10.5771/9783845262321
  211. Biocon (2010), Biocon Biopharmaceuticals Private Limited becomes wholly owned subsidiary of Biocon, 05. April, <http://www.biocon.com/biocon_press_release_ Open Google Scholar DOI: 10.5771/9783845262321
  212. details.asp?subLink=news&Fileid=384>. Open Google Scholar DOI: 10.5771/9783845262321
  213. Biocon (2012), Biocon announces that it has entered into an option agreement with Bristol-Myers Squibb for Biocon’s IN-105, an oral insulin drug candidate, 16. November, <http://www.biocon.com/biocon_inv_press_releases_16112012.asp>. Open Google Scholar DOI: 10.5771/9783845262321
  214. Bird, Robert & Daniel R. Cahoy (2008), The Impact of Compulsory Licensing on Foreign Direct Investment: A Collective Bargaining Approach, American Business Law Journal, 45(2), 283-330. Open Google Scholar DOI: 10.5771/9783845262321
  215. Bloch, Harry (Hrsg.) (2003), Growth and development in the global economy, Cheltenham: Edward Elgar. Open Google Scholar DOI: 10.5771/9783845262321
  216. Blomstrom, Magnus, Robert E. Lipsey & Mario Zejan (1992), What explains developing country growth?, NBER Working Paper Series, No. 4132, Cambridge: National Bureau of Economic Research. Open Google Scholar DOI: 10.5771/9783845262321
  217. Bloomberg Businessweek (2013), Dr. Reddy's Laboratories, <http://investing. Open Google Scholar DOI: 10.5771/9783845262321
  218. businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=DRRD:IN>. Open Google Scholar DOI: 10.5771/9783845262321
  219. BMI (2011), Roche Signs Technology-Transfer Deal With Government-Run Drugmaker, Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions, Business Monitor International, April. Open Google Scholar DOI: 10.5771/9783845262321
  220. BMI (2012a), DSM To Manufacture Recepta's Antibodies, News and analysis on global M&A and corporate financing strategies, Business Monitor International, Juli. Open Google Scholar DOI: 10.5771/9783845262321
  221. BMI (2012b), New Joint Ventures Between Multinationals And Local Drugmakers, News and analysis on global M&A and corporate financing strategies, Business Monitor International, Februar. Open Google Scholar DOI: 10.5771/9783845262321
  222. BMI (2012c), Pharmaceutical Trade Surplus To Widen, Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions, Business Monitor International, März 2012. Open Google Scholar DOI: 10.5771/9783845262321
  223. Börzel, Tanja A. (2008), Der "Schatten der Hierarchie" — Ein Governance-Paradox?, in: Gunnar Folke Schuppert & Michael Zürn (Hrsg.), Governance in einer sich wandelnden Welt, Wiesbaden: VS Verlag für Sozialwissenschaften, 118-131. Open Google Scholar DOI: 10.5771/9783845262321
  224. Botzem, Sebastian (2002), Governance-Ansätze in der Steuerungsdiskussion: Steuerung und Selbstregulierung unter den Bedingungen fortschreitender Internationalisierung Discussion Paper, FS I 02 -106, Berlin: Wissenschaftszentrum Berlin für Sozialforschung,. Open Google Scholar DOI: 10.5771/9783845262321
  225. Bower, D. Jane & Julian C. Sulej (2007), The Indian Challenge: The Evolution of a Successful New Global Strategy in the Pharmaceutical Industry, Technology Analysis & Strategic Management, 19(5), 611-624. Open Google Scholar DOI: 10.5771/9783845262321
  226. Braczyk, Hans-Joachim, Philip Cooke & Martin Heidenreich (Hrsg.) (1998), Regional Innovation Systems: The role of governances in a globalized world, London: UCL Press. Open Google Scholar DOI: 10.5771/9783845262321
  227. Brooks, Sarah M. (2004), Explaining Capital Account Liberalization in Latin America: A Transitional Cost Approach, World Politics, 56(3), 389-430. Open Google Scholar DOI: 10.5771/9783845262321
  228. Bruton, Henry (1989), Import Substitution, in: Hollis Chenery & T.N. Srinivasan (Hrsg.), Handbook of Development Economics, 2, Amsterdam: Elsevier, 1601-1644. Open Google Scholar DOI: 10.5771/9783845262321
  229. Business Standard (2004a), Biocon denies deaths in trials, 24.08.04. Open Google Scholar DOI: 10.5771/9783845262321
  230. Business Standard (2004b), Syngene in research deal with Novartis, 01.09.04. Open Google Scholar DOI: 10.5771/9783845262321
  231. Business Standard (2005), Glenmark, Teijin announce $53mn deal, Mumbai, April 26, 2005. Open Google Scholar DOI: 10.5771/9783845262321
  232. Business Standard (2009), Lupin out-licenses drug to US major Salix, 06.10.09. Open Google Scholar DOI: 10.5771/9783845262321
  233. Business Standard (2012), Pharma majors named in clinical trial death list, 24.07.12. Open Google Scholar DOI: 10.5771/9783845262321
  234. BusinessWire (2007), Merck & Co., Inc. Statement on Brazilian Government's Decision To Issue Compulsory License for STOCRIN, 04.05.07. Open Google Scholar DOI: 10.5771/9783845262321
  235. BusinessWire (2010), Dr. Reddy's and Rheoscience Announce Headline Results from First Phase III Clinical Trial of Balaglitazone (DRF 2593), 04.01.10. Open Google Scholar DOI: 10.5771/9783845262321
  236. Businessworld (2010), Death of a Dream, 08.02.10, <http://www.businessworld.in/ Open Google Scholar DOI: 10.5771/9783845262321
  237. news/business/pharma/death-of-a-dream/460435/page-1.html>. Open Google Scholar DOI: 10.5771/9783845262321
  238. Cadila Healthcare (2013), Zydus pioneers a breakthrough with LIPAGLYN, India’s first NCE to reach the market, 05.06.13. Open Google Scholar DOI: 10.5771/9783845262321
  239. Caliari, Thiago & Ricardo Ruiz (2010), Structure and Innovation in Pharmaceutical Industry in Brazil: The Impact of Generic Drugs, DRUID-DIME Academy Winter Conference 2010, Aalborg, 21.-23. Januar. Open Google Scholar DOI: 10.5771/9783845262321
  240. Campos, Claudio Maggi (2006), The Salmon Farming and Processing Cluster in Southern Chile, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 109-140. Open Google Scholar DOI: 10.5771/9783845262321
  241. Casas, Carmen Nila Phang Romero (2009), O complexo industrial da saúde na área farmacêutica: uma discussão sobre inovação e acesso no Brasil, Tese apresentada com vistas à obtenção do título de Doutor em Ciências na área de Saúde Pública, Rio de Janeiro: Escola Nacional de Saúde Pública. Open Google Scholar DOI: 10.5771/9783845262321
  242. Cassier, Maurice (2013), Pharmaceutical Patent Law In-the-Making: Opposition and Legal Action by States, Citizens, and Generics Laboratories in Brazil and India, in: Jean-Paul Gaudillière & Volker Hess (Hrsg.), Ways of Regulating Drugs in the 19th and 20th Centuries, Basingstoke: Palgrave Macmillan. Open Google Scholar DOI: 10.5771/9783845262321
  243. Cassier, Maurice & Carlos Correa (2003), Patents, Innovation and Public Health: Brazilian Public-Sector Laboratories’ Experience in Copying AIDS Drugs, in: Jean-Paul Moatti et al. (Hrsg.), Economics of AIDS and Access to HIV/AIDS Care in Developing Countries: Issues and Challenges, Paris: ANRS, Collection Sciences Sociales et Sida, 89-107. Open Google Scholar DOI: 10.5771/9783845262321
  244. Cassier, Maurice & Carlos Correa (2008), Scaling-up and reverse engineering: acquisition of industrial knowledge by copying drugs in Brazil, in: Benjamin Coriat (Hrsg.), The Political Economy of HIV/AIDS in Developing Countries: TRIPS, Public Health Systems and Free Access, Cheltenham: Edward Elgar, 130-149. Open Google Scholar DOI: 10.5771/9783845262321
  245. Cassier, Maurice & Marilena Correa (2007), Intellectual Property and Public Health: Coping of HIV/aids drugs by Brazilian public and private pharmaceutical laboratories, Electronic Journal of Communication, Information and Innovation in Health, 1(1), 83-90. Open Google Scholar DOI: 10.5771/9783845262321
  246. Cechinel-Filho, Valdir (Hrsg.) (2012), Plant Bioactives and Drug Discovery: Principles, Practice, and Perspectives, Hoboken: Wiley. Open Google Scholar DOI: 10.5771/9783845262321
  247. Centad (2010), Competition Law and Indian Pharmaceutical Industry, New Delhi: Centre for Trade and Development. Open Google Scholar DOI: 10.5771/9783845262321
  248. Chadha, Alka (2009), TRIPs and patenting activity: Evidence from the Indian pharmaceutical industry, Economic Modelling, 26(2), 499-505. Open Google Scholar DOI: 10.5771/9783845262321
  249. Chagti, Anuradha Sharma (2007), Intellectual Property Rights and Development: Strategies for Developing Countries, Journal of Development and Social Transformation, 3, 27-35. Open Google Scholar DOI: 10.5771/9783845262321
  250. Chamas, Claudia Ines (2005), Developing Innovative Capacity in Brazil to meet Health Needs, in: Ingrid Hering (Hrsg.), Innovation in Developing Countries to Meet Health Needs: Experiences of China, Brazil, South Africa and India, Oxford: The Centre for Management of IP in Health R&D, 75-111. Open Google Scholar DOI: 10.5771/9783845262321
  251. Chamber of Deputies (2013), Brazil's Patent Reform: Innovation Towards National Competitiveness, Brasília: Chamber of Deputies, Center for Strategic Studies and Debates. Open Google Scholar DOI: 10.5771/9783845262321
  252. Chang, Ha-Joon (2002), Kicking Away the Ladder: Development Strategy in Historical Perspective, London: Anthem Press. Open Google Scholar DOI: 10.5771/9783845262321
  253. Chataway, Joanna et al. (2007), Building the Case for National Systems of Health Innovation, A Background Policy Paper prepared for NEPAD in advance of the AMCOST meeting and the African Union Summit, Pretoria: NEPAD. Open Google Scholar DOI: 10.5771/9783845262321
  254. Chataway, Joanna, Dinar Kale & David Wield (2007), The Indian Pharmaceutical Industry Before and After Trips, Technology Analysis & Strategic Management, 19(5), 559-563. Open Google Scholar DOI: 10.5771/9783845262321
  255. Chataway, Joanna, Joyce Tait & David Wield (2007), Frameworks for Pharmaceutical Innovation in Developing Countries: The Case of Indian pharma, Technology Analysis and Strategic Management, 19(5), 697-708. Open Google Scholar DOI: 10.5771/9783845262321
  256. Chaturvedi, Kalpana & Joanna Chataway (2006), Innovation in the Post-TRIPs Regime in Indian Pharmaceutical Firms: Implications for Pharmaceutical Model, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  257. Chaturvedi, Kalpana, Joanna Chataway & David Wield (2007), Policy, Markets and Knowledge: Strategic Synergies in Indian Pharmaceutical Firms, Technology Analysis & Strategic Management, 19(5), 565-588. Open Google Scholar DOI: 10.5771/9783845262321
  258. Chaudhuri, Sudip (1984), Manufacturing Drugs without TNCs: Status of Indigenous Sector in India, Economic & Political Weekly, 19(30), 1341-1383. Open Google Scholar DOI: 10.5771/9783845262321
  259. Chaudhuri, Sudip (2005), The WTO and India's Pharmaceuticals Industry: Patent Protection, TRIPS, and Developing Countries, Oxford: Oxford University Press. Open Google Scholar DOI: 10.5771/9783845262321
  260. Chaudhuri, Sudip (2008), Is Product Patent Protection Necessary to Spur Innovation in Developing Countries?, in: Neil Weinstock Netanel (Hrsg.), The Development Agenda, Global Intellectual Property and Developing Countries, New York: Oxford University Press, 265-292. Open Google Scholar DOI: 10.5771/9783845262321
  261. Chaudhuri, Sudip (2007), The Gap Between Successful Innovation and Access to its Benefits: Indian Pharmaceuticals, The European Journal of Development Research, 19(1), 49-65. Open Google Scholar DOI: 10.5771/9783845262321
  262. Chaves, Gabriela Costa & Maria Auxiliadora Oliveira (2007), Measuring the degree of public health sensitivity of patent legislation in the context of the WTO TRIPS Agreement, Bulletin of the World Health Organization, 85(1), 49-56. Open Google Scholar DOI: 10.5771/9783845262321
  263. Chaves, Gabriela Costa, Marcela Fogaça Vieira & Renata Reis (2008), Access to medicines and intellectual property in Brazil: reflections and strategies of civil society, Sur – Revista Internacional de Direitos Humanos, 5(8), 163-189. Open Google Scholar DOI: 10.5771/9783845262321
  264. Choung, Jae-Yong, Hye-Ran Hwang & Jin-Ho Choi (2000), Transition of Latecomer Firms from Technology Users to Technology Generators: Korean Semiconductor Firms, World Development, 28(5), 969-982. Open Google Scholar DOI: 10.5771/9783845262321
  265. Cimoli, Mario & Gabriel Porcile (2009), Sources of learning paths and technological capabilities: an introductory roadmap of development processes, Economics of Innovation and New Technology, 18(7), 675-694. Open Google Scholar DOI: 10.5771/9783845262321
  266. Clinton Health Access Initiative (2013), ARV Ceiling Price List (August 2013), <http://www.clintonhealthaccess.org/news-and-information/ Open Google Scholar DOI: 10.5771/9783845262321
  267. ARV-Ceiling-Price-List-May-2013>. Open Google Scholar DOI: 10.5771/9783845262321
  268. CNCTIS (2004), 2ª Conferência Nacional de Ciência, Tecnologia e Inovação em Saúde, Brasília: Ministério da Saúde. Open Google Scholar DOI: 10.5771/9783845262321
  269. CNS (2004), Resolução No. 338, de 6 de Maio de 2004, Diário Oficial da União - Seção 1, Brasília: Conselho Nacional de Saúde. Open Google Scholar DOI: 10.5771/9783845262321
  270. Coe, Neil M. & Timothy G. Bunnell (2003), ‘Spatializing’ knowledge communities: towards a conceptualization of transnational innovation networks, Global Networks, 3(4), 437-456. Open Google Scholar DOI: 10.5771/9783845262321
  271. Cohen, Jillian Clare (2006), Expanding Drug Access in Brazil, Canadian Journal of Public Health, 97(6), 15-18. Open Google Scholar DOI: 10.5771/9783845262321
  272. Cohen, Jillian Clare & Kristina M. Lybecker (2005), Aids Policy and Pharmaceutical Patents: Brazil's Strategy to Safeguard Public Health, The World Economy, 28(2), 211-230. Open Google Scholar DOI: 10.5771/9783845262321
  273. Cohen, Wesley M. & Daniel A. Levinthal (1990), Absorptive Capacity: A New Perspective on Learning and Innovation, Administrative Science Quarterly, 35(1), 128-152. Open Google Scholar DOI: 10.5771/9783845262321
  274. Cooke, Philip (1993), Regional innovation networks: An evaluation of six European cases, Topos, 6, 1-30. Open Google Scholar DOI: 10.5771/9783845262321
  275. Cooke, Philip (1998), Introduction: Origins of the Concept, in: Hans-Joachim Braczyk et al. (Hrsg.), Regional Innovation Systems: The role of governances in a globalized world, London: UCL Press, 2-25. Open Google Scholar DOI: 10.5771/9783845262321
  276. Coombs, Rod, Paolo Saviotti & Vivien Walsh (Hrsg.) (1992), Technical change and company strategies: economic and sociological perspectives, London: Academy Press. Open Google Scholar DOI: 10.5771/9783845262321
  277. Coriat, Benjamin & Olivier Weinstein (2002), Organizations, firms and institutions in the generation of innovation, Research Policy, 31(2), 273-290. Open Google Scholar DOI: 10.5771/9783845262321
  278. Coriat, Benjamin & Olivier Weinstein (2012), Patent regimes, firms and the commodification of knowledge, Socio-Economic Review, 10(2), 267-292. Open Google Scholar DOI: 10.5771/9783845262321
  279. Correa, Carlos M. (2011), Pharmaceutical Innovation, Incremental Patenting and Compulsory Licensing, South Centre Research Paper, No. 41, Geneva: South Centre,. Open Google Scholar DOI: 10.5771/9783845262321
  280. Costa, Laís Silveira, Carlos Augusto Grabois Gadelha & Antoine Metten (2012), Saúde e Desenvolvimento no Brasil: estado da arte e desafios, Resumo aprovado para apresentação pôster na VI Jornada Nacional de Economica da Saúde, Brasília, 17.-19. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  281. Costinot, Arnaud (2009), An Elementary Theory of Comparative Advantage, NBER Working Paper, No. 14645, Cambridge: National Bureau of Economic Research. Open Google Scholar DOI: 10.5771/9783845262321
  282. Cozzens, Susan E. & Raphael Kaplinsky (2009), Innovation, poverty and inequality: cause, coincidence, or co-evolution?, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 57-82. Open Google Scholar DOI: 10.5771/9783845262321
  283. Cozzens, Susan, Sonia Gatchair & Dhanaraj Thakur (2006), Distributional Assessment of Emerging Technologies: A Framework Analysis, James Martin Institute Working Paper, 1. Open Google Scholar DOI: 10.5771/9783845262321
  284. Creswell, John W. (2003), Research Design: Qualitative, Quantitative, and Mixed Methods Approaches, Thousand Oaks: Sage. Open Google Scholar DOI: 10.5771/9783845262321
  285. CSDD (2010), Outlook 2010, Boston: Tufts Center for the Study of Drug Development. Open Google Scholar DOI: 10.5771/9783845262321
  286. Cullet, Philippe (2001), Patents Bill, TRIPs and Right to Health, Economic & Political Weekly, 36(43), 4049-4051. Open Google Scholar DOI: 10.5771/9783845262321
  287. D'Mello, Bernard (2002), Transnational Pharmaceutical Corporations and Neo-Liberal Business Ethics in India, Journal of Business Ethics, 36(1-2), 165-185. Open Google Scholar DOI: 10.5771/9783845262321
  288. Da Gama Camara Jr, Eduardo (2013), Brazil: Prosecution Of Pharmaceutical Patents In Brazil: Tensions Between The Brazilian Patent Office And ANVISA, <http://www.mondaq.com/article.asp?articleid=253068>. Open Google Scholar DOI: 10.5771/9783845262321
  289. Dahlmann, Carl (2010), Innovation Strategies in Brazil, China and India: From Imitation to Deepening Technological Capability in the South, in: Xiaolan Fu & Luc Soete (Hrsg.), The Rise of Technological Power in the South, Basingstoke: Palgrave Macmillan, 15-48. Open Google Scholar DOI: 10.5771/9783845262321
  290. Damodaran, A. (2008), Indian Patent Law in the post-TRIPS Decade: S & T Policy Appraisal, Journal of Intellectual Property Rights, 13, 414-423. Open Google Scholar DOI: 10.5771/9783845262321
  291. Datta, P. T. Jyothi (2013), Health Ministry scrambles to procure TB drugs, The Hindu Business Line, 23.06.13. Open Google Scholar DOI: 10.5771/9783845262321
  292. David, Paul A. & Dominique Foray (2002), An introduction to the economy of the knowledge society, International Social Science Journal, 54(171), 9-23. Open Google Scholar DOI: 10.5771/9783845262321
  293. Davies, Louise (2002), Technical Cooperation and the International Coordination of Patentability of Biotechnological Inventions, Journal of Law and Society, 29(1), 137-162. Open Google Scholar DOI: 10.5771/9783845262321
  294. de Brito Cruz, Carlos Henrique & Hernan Chaimovich (2010), Brazil, in: Susan Schneegans (Hrsg.), UNESCO Science Report 2010, Paris: UNESCO Publishing, 103-121. Open Google Scholar DOI: 10.5771/9783845262321
  295. de Brito Cruz, Carlos Henrique & Luiz de Mello (2006), Boosting Innovation Performance in Brazil, OECD Economics Department Working Papers, No. 532, Paris: OECD Publishing. Open Google Scholar DOI: 10.5771/9783845262321
  296. De La Rosa, Sybille & Matthias Kötter (2008), Governance(-forschung) im Kontext der Disziplinen, in: Sybille De La Rosa et al. (Hrsg.), Transdisziplinäre Governanceforschung: Gemeinsam hinter den Staat blicken, Baden-Baden: Nomos, 11-33. Open Google Scholar DOI: 10.5771/9783845262321
  297. Deardoff, Alan V. (1992), Welfare Effects of Global Patent Protection, Economica, 59(233), 35-51. Open Google Scholar DOI: 10.5771/9783845262321
  298. DGVN (2011), Nachhaltigkeit und Gerechtigkeit: Eine bessere Zukunft für alle, Bericht über die menschliche Entwicklung 2011, Berlin: Deutsche Gesellschaft für die Vereinten Nationen. Open Google Scholar DOI: 10.5771/9783845262321
  299. Di Giorgio, Rosana Ceron (2007), From University to Industry: Technology Transfer at Unicamp in Brazil, in: Anatole Krattiger et al. (Hrsg.), Intellectual Property Management in Health and Agricultural Innovation: a handbook of best practices, Oxford: MIHR, 1747-1752. Open Google Scholar DOI: 10.5771/9783845262321
  300. Diário da Saúde (2010), Brasil produzirá medicamento biotecnológico para doença de Gaucher, <http://www.diariodasaude.com.br/news.php?article= Open Google Scholar DOI: 10.5771/9783845262321
  301. remedio-doenca-gaucher&id=5790>. Open Google Scholar DOI: 10.5771/9783845262321
  302. Dicken, Peter (2003), Global Shift: Reshaping the Global Economic Map in the 21st Century, London: Sage. Open Google Scholar DOI: 10.5771/9783845262321
  303. Dicken, Peter et al. (2001), Chains and networks, territories and scales: towards a relational framework for analysing the global economy, Global Networks, 1(2), 89-112. Open Google Scholar DOI: 10.5771/9783845262321
  304. DIPP (2010), Discussion Paper: Compulsory Licencing, Department of Industrial Policy & Promotion, Government of India, Ministry of Commerce & Industry, New Delhi. Open Google Scholar DOI: 10.5771/9783845262321
  305. DIPP (2013), SIA Newsletter February 2013, Department of Industrial Policy & Promotion, Government of India, Ministry of Commerce & Industry, New Delhi. Open Google Scholar DOI: 10.5771/9783845262321
  306. Doloreux, David & Saeed Parto (2005), Regional innovation systems: Current discourse and unresolved issues, Technology in Society, 27(2), 133-153. Open Google Scholar DOI: 10.5771/9783845262321
  307. Dos Santos, L. & I. Heineck (2012), Drug utilization study in pediatric prescriptions of a university hospital in southern brazil: off-label, unlicensed and high-alert medications, Farmacia Hospitalaria, 36(4), 180-186. Open Google Scholar DOI: 10.5771/9783845262321
  308. Dosi, Giovanni (1988), The nature of the innovative process, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 221-238. Open Google Scholar DOI: 10.5771/9783845262321
  309. Dosi, Giovanni & Luc Soete (1988), Technological change and international trade, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 401-431. Open Google Scholar DOI: 10.5771/9783845262321
  310. Dr. Reddy's (2002), Annual Report 2001-2002, Hyderabad, <http://www.drreddys.com/investors/pdf/annualreport2002.pdf>. Open Google Scholar DOI: 10.5771/9783845262321
  311. Drahos, Peter & John Braithwaite (2002), Information Feudalism, London: Earthscan Publications. Open Google Scholar DOI: 10.5771/9783845262321
  312. Draude, Anke (2007), How to Capture Non-Western Forms of Governance: In Favour of an Equivalence Functionalist Observation of Governance in Areas of Limited Statehood, SFB-Governance Working Paper Series, Berlin: Research Center (SFB) 700. Open Google Scholar DOI: 10.5771/9783845262321
  313. Dreyfuss, Rochelle (2009), The Role of India, China, Brazil and Other Emerging Economies in Establishing Access Norms for Intellectual Property and Intellectual Property Lawmaking, International Law and Justice Working Papers, No. 5, New York: Institute for International Law and Justice, New York University School of Law. Open Google Scholar DOI: 10.5771/9783845262321
  314. DSF (oJ), Selling Out To MNCs: R&D Deal Between Glaxo And Ranbaxy By Amit Sen Gupta, Delhi Science Forum, <http://www.delhiscienceforum.net/ Open Google Scholar DOI: 10.5771/9783845262321
  315. pharmaceuticals/245-selling-out-to-mncs-rad-deal-between-glaxo-and-ranba Open Google Scholar DOI: 10.5771/9783845262321
  316. xy-by-amit-sen-gupta-.html>. Open Google Scholar DOI: 10.5771/9783845262321
  317. DTOLA (2011a), Flawed agreement – BMS Matrix agreement on AIDS drug, 29.06.11. Open Google Scholar DOI: 10.5771/9783845262321
  318. DTOLA (2011b), Will India go for Compulsory Licensing for providing improved access to life saving medicines?, 11.04.11. Open Google Scholar DOI: 10.5771/9783845262321
  319. DTOLA (2012), BMS sues Mylan (Matrix) Labs for selling generic version of HIV drug Atazanavir to PAHO, 03.08.12. Open Google Scholar DOI: 10.5771/9783845262321
  320. Eaton, Jonathan & Samuel Kortum (1995), Engines of Growth: Domestic and Foreign Sources of Innovation, NBER Working Paper Series, No. 5207, Cambridge: National Bureau of Economic Research,. Open Google Scholar DOI: 10.5771/9783845262321
  321. Ecks, Stefan (2008), Global pharmaceutical markets and corporate citizenship: the case of Novartis' anti-cancer drug Glivec, BioSocieties, 3, 165-181. Open Google Scholar DOI: 10.5771/9783845262321
  322. Economic Times (2002), Ranbaxy ends two pacts with Eli Lilly, 01.02.02. Open Google Scholar DOI: 10.5771/9783845262321
  323. Economic Times (2003), Matrix reloaded with more products, 28.07.03. Open Google Scholar DOI: 10.5771/9783845262321
  324. Economic Times (2005), Will Vision Garuda help Ranbaxy become a high flyer?, 15.10.05. Open Google Scholar DOI: 10.5771/9783845262321
  325. Economic Times (2006a), AIDS drug Viread prices may dip soon, 04.09.06. Open Google Scholar DOI: 10.5771/9783845262321
  326. Economic Times (2006b), US pharma major Mylan buys Matrix Labs, 29.08.06. Open Google Scholar DOI: 10.5771/9783845262321
  327. Economic Times (2006c), Wockhardt signs in-licensing agreement with UK, 05.06.06. Open Google Scholar DOI: 10.5771/9783845262321
  328. Economic Times (2011a), Failures and doubting investors have not dissuaded Glenmark Pharma's Glenn Saldanha, 22.05.11. Open Google Scholar DOI: 10.5771/9783845262321
  329. Economic Times (2011b), Lupin signs strategic deal with Brazilian firm Farmanguinhos, 05.01.11. Open Google Scholar DOI: 10.5771/9783845262321
  330. Economic Times (2011c), Natco Pharma files India's first compulsory licence plea, 02.08.11. Open Google Scholar DOI: 10.5771/9783845262321
  331. Economic Times (2011d), No additional norms to issue compulsory drug licences, 12.04.11. Open Google Scholar DOI: 10.5771/9783845262321
  332. Economic Times (2012), Emcure signs deal to manufacture Roche's anti-cancer drugs, 02.03.12. Open Google Scholar DOI: 10.5771/9783845262321
  333. Economic Times (2013a), Compulsory licence likely for three cancer drugs, 14.01.13. Open Google Scholar DOI: 10.5771/9783845262321
  334. Economic Times (2013b), Swiss drug major Roche to drop anti-cancer drug Herceptin patent in India, 16.08.13. Open Google Scholar DOI: 10.5771/9783845262321
  335. Edquist, Charles (Hrsg.) (1997), Systems of Innovation: Technologies, Institutions and Organisations, London: Pinter. Open Google Scholar DOI: 10.5771/9783845262321
  336. Edquist, Charles (2001a), The Systems of Innovation Approach and Innovation Policy: An account of the state of the art, Lead paper presented at the DRUID Conference, Aalborg, 12.-15. Juni. Open Google Scholar DOI: 10.5771/9783845262321
  337. Edquist, Charles (2001b), Systems of Innovation for Development (SID), Background Paper for Chapter I: «Competitiveness, Innovation and Learning: Analytical Framework” for the UNIDO World Industrial Development Report (WIDR), 2001, Linköping: Department of Technology and Social Change, Linköping University, 31.01.01. Open Google Scholar DOI: 10.5771/9783845262321
  338. Edquist, Charles (2005), Systems of Innovation: Perspectives and Challenges, in: Jan Fagerberg et al. (Hrsg.), Oxford Handbook of Innovation, Oxford: Oxford University Press, 181-208. Open Google Scholar DOI: 10.5771/9783845262321
  339. Edquist, Charles & Leif Hommen (2006), Comparing National Systems of Innovation in Asia and Europe: Growth, Globalisation, Change and Policy, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  340. Edquist, Charles & Bengt-Åke Lundvall (1993), Comparing the Danish and Swedish Systems of Innovation, in: Richard R. Nelson (Hrsg.), National Innovation Systems: A Comparative Analysis, Oxford: Oxford University Press, 265-297. Open Google Scholar DOI: 10.5771/9783845262321
  341. Eimer, Thomas R. & Susanne Lütz (2010), Developmental States, Civil Society and Public Health: Patent Regulation for HIV/AIDS Vaccines in India and Brazil, Regulation and Governance, 4(2), 135-153. Open Google Scholar DOI: 10.5771/9783845262321
  342. Eimer, Thomas R., Susanne Lütz & Verena Schüren (2013), Norm diffusion through Advocacy Coalitions: Implementing international intellectual property norms in India and Brazil, ISA 54th Annual Convention, San Francisco, 03.-07. April. Open Google Scholar DOI: 10.5771/9783845262321
  343. Eimer, Thomas R. & Verena Schüren (2013), Convenient Stalemates: Why International Patent Law Negotiations continue despite Deadlock, New Political Economy, 18(4), 533-554. Open Google Scholar DOI: 10.5771/9783845262321
  344. Eren-Vural, Ipek (2007), Domestic contours of global regulation, Understanding the policy changes on pharmaceutical patents in India and Turkey, Review of International Political Economy, 14(1), 105-142. Open Google Scholar DOI: 10.5771/9783845262321
  345. Ernst & Young Terco (2011), Doing business in Brazil, <http://www.ey.com/ Open Google Scholar DOI: 10.5771/9783845262321
  346. Publication/vwLUAssets/Doing_business_in_Brazil_2011/$FILE/Doing% Open Google Scholar DOI: 10.5771/9783845262321
  347. 20Business%20in%20Brazil%202011.pdf>. Open Google Scholar DOI: 10.5771/9783845262321
  348. Ernst, Dieter (1994), What are the Limits to the Korean Model? The Korean Electronics Industry Under Pressure, BRIE research paper, Berkeley: University of California,. Open Google Scholar DOI: 10.5771/9783845262321
  349. Ernst, Dieter (2002), Global production networks and the changing geography of innovation systems: Implications for developing countries, Economics of Innovation and New Technology, 11(6), 497-523. Open Google Scholar DOI: 10.5771/9783845262321
  350. Ernst, Dieter, Tom Ganiatsos & Lynn Mytelka (Hrsg.) (1998), Technological Capabilities and Export Success in East Asia, London: Routledge. Open Google Scholar DOI: 10.5771/9783845262321
  351. Eßer, Klaus et al. (2001), Systemische Wettbewerbsfähigkeit und Entwicklung, in: Reinold E. Thiel (Hrsg.), Neue Ansätze zur Entwicklungstheorie, Bonn: DSE/IZEP, 147-163. Open Google Scholar DOI: 10.5771/9783845262321
  352. Estadão.com.br (2011), Governo faz acordo para produzir novos medicamentos, <http://www.estadao.com.br/noticias/impresso,governo-faz-acordo-para-produ Open Google Scholar DOI: 10.5771/9783845262321
  353. zir-novos-medicamentos,702296,0.htm>. Open Google Scholar DOI: 10.5771/9783845262321
  354. Evans, Peter (1995), Embedded Autonomy: States and Industrial Transformation, Princeton: Princeton University Press. Open Google Scholar DOI: 10.5771/9783845262321
  355. EXIM Bank of India (2007), Indian Pharmaceutical Industry: Surging Globally, Occasional Paper, No. 119, Mumbai: Export-Import Bank of India,. Open Google Scholar DOI: 10.5771/9783845262321
  356. Expressindia (2000), Wockhardt, German partner unveil vaccine for hepatitis-B, 13.03.00. Open Google Scholar DOI: 10.5771/9783845262321
  357. Expressindia (2001), Allergan, Nicholas Piramal to strengthen JV, 28.03.01. Open Google Scholar DOI: 10.5771/9783845262321
  358. Fagerberg, Jan (1996), Technology and competitiveness, Oxford Review of Economic Policy, 12(3), 39-51. Open Google Scholar DOI: 10.5771/9783845262321
  359. Fagerberg, Jan & Martin Srholec (2008), National innovation systems, capabilities and economic development, Research Policy, 37(9), 1417-1435. Open Google Scholar DOI: 10.5771/9783845262321
  360. Feinson, Stephen (2003), National Innovation Systems Overview and Country Cases, in: CSPO et al. (Hrsg.), Knowledge Flows and Knowledge Collectives: Understanding The Role of Science and Technology Policies in Development, Volume 1: Knowledge Flows, Innovation, and Learning in Developing Countries, New York: Global Inclusion Program of the Rockefeller Foundation, 13-38. Open Google Scholar DOI: 10.5771/9783845262321
  361. Ferrer, Marcela et al. (2004), The scientific muscle of Brazil’s health biotechnology, Nature Biotechnology, 22(12s), DC8 - DC12. Open Google Scholar DOI: 10.5771/9783845262321
  362. Ferro do Lago, Regina & Nilson do Rosário Costa (2009), Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program, Cadernos de Saúde Pública, 25(10), 2273-2284. Open Google Scholar DOI: 10.5771/9783845262321
  363. FierceBiotech (2008), Wockhardt takes huge strides towards In-licensing and collaborative agreements, 10.10.08. Open Google Scholar DOI: 10.5771/9783845262321
  364. Filho, Jorge Elisa Kalil (2011), Panorama regulatório da pesquisa no Brasil, in: Ricardo Ubiraci Sennes & Antonio Britto Filho (Hrsg.), Inovações tecnológicas no Brasil, São Paulo: Cultura Acadêmica, 233-266. Open Google Scholar DOI: 10.5771/9783845262321
  365. Filho, Pedro Lins Palmeira & Luciana Xavier de Lemos Capanema (2010), A Cadeia Farmacêutica Nacional E O Desafio Da Inovação: Possibilidades Para A Atuação Do Bndes E Outros Agentes, XXX Encontro Nacional De Engenharia De Produção, São Carlos, 07. September. Open Google Scholar DOI: 10.5771/9783845262321
  366. Finanznachrichten (2006), Dr. Reddy's, ClinTec pen cancer drug pact, 27.09.06. Open Google Scholar DOI: 10.5771/9783845262321
  367. Fiocruz (2011), Medicamento para pacientes transplantados, Open Google Scholar DOI: 10.5771/9783845262321
  368. <http://www2.far.fiocruz.br/farmanguinhos/index.php?option=com_content&view=article&id=298:farmanguinhos-vai-produzir-medicamento-para-pacien Open Google Scholar DOI: 10.5771/9783845262321
  369. tes-transplantados&catid=53:outras-noticias&Itemid=94>. Open Google Scholar DOI: 10.5771/9783845262321
  370. Firstpost (2012), Cipla’s brave act: Will cancer treatment go the AIDS way?, 12.11.12, <http://www.firstpost.com/business/ciplas-brave-act-will-cancer-treat Open Google Scholar DOI: 10.5771/9783845262321
  371. ment-go-the-aids-way-523057.html>. Open Google Scholar DOI: 10.5771/9783845262321
  372. Floricel, Serghei, John Michela & Mark George (2009), Resource Feedbacks for Continuous Innovation: The Articulation of Firm, University, and Government Roles, Summer Conference 2009 on Copenhagen Business School, Frederiksberg, 17.-19. Juni. Open Google Scholar DOI: 10.5771/9783845262321
  373. Flynn, Matthew (2008), Public Production of Anti-Retroviral Medicines in Brazil, 1990-2007, Development and Change, 39(4), 513-536. Open Google Scholar DOI: 10.5771/9783845262321
  374. Focus Reports (2012), Brazil: Pharma Report, <http://issuu.com/focusreports/docs/ Open Google Scholar DOI: 10.5771/9783845262321
  375. phex_brazil_2012>. Open Google Scholar DOI: 10.5771/9783845262321
  376. Folha de S.Paulo (2012), Novartis e Furp fecham acordo de transferência, 09.11.12. Open Google Scholar DOI: 10.5771/9783845262321
  377. Fransman, Martin (1984), Technological Capability in the Third World: An Overview and Introduction to some of the Issues raised in this Book, in: Martin Fransman & Kenneth King (Hrsg.), Technological Capability in the Third World, London: Macmillan, 3-30. Open Google Scholar DOI: 10.5771/9783845262321
  378. Freeman, Chris (1995), The 'National System of Innovation' in historical perspective, Cambridge Journal of Economics, 19(1), 5-24. Open Google Scholar DOI: 10.5771/9783845262321
  379. Freeman, Christopher (1982), The Economics of Industrial Innovation, Cambridge: MIT Press. Open Google Scholar DOI: 10.5771/9783845262321
  380. Freeman, Christopher (1987), Technology Policy and Economic Performance: Lessons from Japan, London: Pinter. Open Google Scholar DOI: 10.5771/9783845262321
  381. Freeman, Christopher (1988), Japan: a new national system of innovation?, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 330-348. Open Google Scholar DOI: 10.5771/9783845262321
  382. Frew, Sarah E. et al. (2007), India's health biotech sector at a crossroads, Nature Biotechnology, 25(4), 403-528. Open Google Scholar DOI: 10.5771/9783845262321
  383. Fritz, Barbara (1999), Implikationen der Asienkrise für das lateinamerikanische Entwicklungsmodell der 90er Jahre, Lateinamerika. Analysen-Daten-Dokumen¬tationen, 16(40), 17-31. Open Google Scholar DOI: 10.5771/9783845262321
  384. Fromhold-Eisebith, Martina (2006), Effectively linking international, national, and regional innovation systems: insights from India and Indonesia, in: Bengt-Åke Lundvall et al. (Hrsg.), Asia’s Innovation Systems in Transition, Cheltenham: Edward Elgar, 75-99. Open Google Scholar DOI: 10.5771/9783845262321
  385. Fu, Xiaolan, Carlo Pietrobelli & Luc Soete (2011), The Role of Foreign Technology and Indigenous Innovation in the Emerging Economies: Technological Change and Catching Up, World Development, 39(7), 1204-1212. Open Google Scholar DOI: 10.5771/9783845262321
  386. Furtado, Celso (1970), Economic Development of Latin America: A Survey from Colonial Times to the Cuban Revolution, Oxford: Oxford University Press. Open Google Scholar DOI: 10.5771/9783845262321
  387. Gadelha, Carlos (2011), A Perspectiva do Complexo Industrial da Saúde: o desenvolvimento industrial e científico do setor e rumos para a assistência farmacêutica, Seminário Valor Econômico Perspectivas do Setor Saúde no Brasil, São Paulo: Valor Econômico S.A., 16. März. Open Google Scholar DOI: 10.5771/9783845262321
  388. Galli, Riccardo & Morris Teubal (1997), Paradigmatic Shifts in National Innovation Systems, in: Charles Edquist (Hrsg.), Systems of Innovation: Technologies, Institutions and Organisations, London: Pinter, 342-370. Open Google Scholar DOI: 10.5771/9783845262321
  389. George, Alexander L. & Andrew Bennett (2005), Case Studies and Theory Development in the Social Sciences, Cambridge: MIT Press. Open Google Scholar DOI: 10.5771/9783845262321
  390. George, Julie, Ramaya Sheshadri & Anand Grover (2009), Intellectual Property and Access to Medicines: Developments and Civil Society Initiatives in India, in: Renata Reis et al. (Hrsg.), Intellectual Property Rights and Access to ARV Medicines: Civil Society Resistance in the Global South, Rio de Janeiro: Brazilian Interdisciplinary AIDS Association, 110-136. Open Google Scholar DOI: 10.5771/9783845262321
  391. Gereffi, Gary (1999), International Trade and Industrial Upgrading in the Apparel Commodity Chain, Journal of International Economics, 48(1), 37-70. Open Google Scholar DOI: 10.5771/9783845262321
  392. Gereffi, Gary (2014), Global value chains in a post-Washington Consensus world, Review of International Political Economy, 21(1), 9-37. Open Google Scholar DOI: 10.5771/9783845262321
  393. Gereffi, Gary, John Humphrey & Timothy Sturgeon (2005), The governance of global value chains, Review of International Political Economy, 12(1), 78-104. Open Google Scholar DOI: 10.5771/9783845262321
  394. Gerring, John (2004), What Is a Case Study and What Is It Good for?, American Political Science Review, 98(2), 341-354. Open Google Scholar DOI: 10.5771/9783845262321
  395. Gerring, John (2007), Case Study Research: Principles and Practices, Cambridge: Cambridge University Press. Open Google Scholar DOI: 10.5771/9783845262321
  396. Gilead Sciences (2011), Gilead Expands Access Program for Medications in Developing World, 12.07.11. Open Google Scholar DOI: 10.5771/9783845262321
  397. Gilead Sciences (2013), Scaling Up Antiretroviral Treatment Sustainably: Gilead Sciences Programs in Developing Countries, November 2013. Open Google Scholar DOI: 10.5771/9783845262321
  398. GIPI (2012), Relatório de Análise e Sugestão de Critérios, Mecanismos, Procedimentos, Obrigações e Possíveis Instrumentos Formais para Articulação Entre a Anvisa e o Inpi com Vistas à Execução do Art. 229-C da Lei No. 9.279/1996, Brasília: Grupo Interministerial de Propriedade Intelectual, 19. Januar. Open Google Scholar DOI: 10.5771/9783845262321
  399. Girtler, Roland (2001), Methoden der Feldforschung, Wien: Böhlau. Open Google Scholar DOI: 10.5771/9783845262321
  400. Girvan, Norman P. (1987), Transnational corporations and non-fuel primary commodities in developing countries, World Development, 15(5), 713-740. Open Google Scholar DOI: 10.5771/9783845262321
  401. Giugale, Marcelo (2011), Yes, They Can: How Emerging Economies Are Building Universal Health Coverage, Huffington Post, 05.07.11. Open Google Scholar DOI: 10.5771/9783845262321
  402. Giuliani, Elisa, Carlo Pietrobelli & Roberta Rabellotti (2005), Upgrading in Global Value Chains: Lessons from Latin American Clusters, World Development, 33(4), 549-573. Open Google Scholar DOI: 10.5771/9783845262321
  403. Gläser, Jochen & Grit Laudel (2004), Experteninterviews und qualitative Inhaltsanalyse, Wiesbaden: VS Verlag für Sozialwissenschaften. Open Google Scholar DOI: 10.5771/9783845262321
  404. globo.com (2008), INPI nega patente ao anti-retroviral Tenofovir, 02.09.08. Open Google Scholar DOI: 10.5771/9783845262321
  405.   Open Google Scholar DOI: 10.5771/9783845262321
  406. Gontijo, Cicero (2005), Die Veränderungen im Patentsystem: Von der Pariser Verbandsübereinkunft zum TRIPS-Abkommen. Die Position Brasiliens, in: Thomas Fritz et al. (Hrsg.), Produktion der Abhängigkeit: Wertschöpfungsketten. Investitionen. Patente, Berlin: Forschungs- und Dokumentationszentrum Chile - Lateinamerika e.V., 79-100. Open Google Scholar DOI: 10.5771/9783845262321
  407. Gopakumar, K.M. (2010), India: A Critical Review of the Implementation of TRIPS Patent Regime, The Law and Development Review, 3(2), 324-368. Open Google Scholar DOI: 10.5771/9783845262321
  408. Gouveia, Roberto (2005), Parliamentary Bill 22/03, Brazil, National Congress. Open Google Scholar DOI: 10.5771/9783845262321
  409. Gräbe, Hans-Gert (2005), Die Macht des Wissens in der modernen Gesellschaft, Utopie kreativ,(177/178), 629-643. Open Google Scholar DOI: 10.5771/9783845262321
  410. Granstrand, Ove (2005), Innovation and Intellectual Property Rights, in: Jan Fagerberg et al. (Hrsg.), The Oxford Handbook of Innovation, Oxford: Oxford University Press, 266-290. Open Google Scholar DOI: 10.5771/9783845262321
  411. Granstrand, Ove (2011), The economics of IP in the context of a shifting innovation paradigm, Contribution to the WIPO Innovation Report 2011 «Shifting Innovation Paradigms and the Role of Intellectual Property”, May. Open Google Scholar DOI: 10.5771/9783845262321
  412. Greenhalgh, Christine & Mark Rogers (2010), Innovation, Intellectual Property, and Economic Growth, Princeton: Princeton University Press. Open Google Scholar DOI: 10.5771/9783845262321
  413. Grosse Ruse-Khan, Henning (2009), Policy Space for Domestic Public Interest Measures Under TRIPS, South Centre Research Papers, No. 22, Geneva: The South Centre, Juli 2009. Open Google Scholar DOI: 10.5771/9783845262321
  414. Grover, Anand (2013), Analysing the Supreme Court Judgment, Economic & Political Weekly, 44(32), 46-49. Open Google Scholar DOI: 10.5771/9783845262321
  415. Gualini, Enrico (2006), Mehrebenen-Governance und neue Formen von Territorialität, in: Ralf Kleinfeld et al. (Hrsg.), Regional Governance: Steuerung, Koordination und Kommunikation in regionalen Netzwerken als neue Formen des Regierens, Düsseldorf: V&R Unipress, 61-82. Open Google Scholar DOI: 10.5771/9783845262321
  416. Guellec, Dominique (2007), Patents as an Incentive to Innovate, in: Dominique Guellec & Bruno van Pottelsberghe de la Potterie (Hrsg.), The Economics of the European Patent System: IP Policy for Innovation and Competition, Oxford: Oxford University Press, 46-84. Open Google Scholar DOI: 10.5771/9783845262321
  417. Guennif, Samira & Shyama V. Ramani (2010), Catching up in pharmaceuticals: a comparative study of India and Brazil, UNU-MERIT Working Papers, No. 19, Maastricht: United Nations University. Open Google Scholar DOI: 10.5771/9783845262321
  418. Guennif, Samira & Shyama V. Ramani (2012), Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework, Research Policy, 41(2), 430-441. Open Google Scholar DOI: 10.5771/9783845262321
  419. Guise Rosina, Monica Steffen, Daniel Wei Liang Wang & Thana Cristina de Campos (2010), Access to Medicines: Pharmaceutical Patents and the Right to Health in: Lea Shaver (Hrsg.), Access to Knowledge in Brazil: New Research on Intellectual Property, Innovation and Development, London: Bloomsbury, 103-134. Open Google Scholar DOI: 10.5771/9783845262321
  420. Hall, Peter A. (2003), Aligning Ontology and Methodology in Comparative Research, in: James Mahoney & Dietrich Rueschemeyer (Hrsg.), Comparative Historical Analysis in the Social Sciences, Cambridge: Cambridge University Press, 373-404. Open Google Scholar DOI: 10.5771/9783845262321
  421. Hall, Peter A. & Kathleen Thelen (2009), Institutional change in varieties of capitalism, Socio-Economic Review, 7(1), 7-34. Open Google Scholar DOI: 10.5771/9783845262321
  422. Hartmann, Jürgen (1995), Vergleichende Politikwissenschaft: Ein Lehrbuch, Frankfurt: Campus. Open Google Scholar DOI: 10.5771/9783845262321
  423. Hasenclever, Lia & Julia Paranhos (2009), The development of the pharmaceutical industry in Brazil and India: technological capability and industrial development, Rio de Janeiro: Federal University, Economics Institute. Open Google Scholar DOI: 10.5771/9783845262321
  424. Hassan, Emmanuel, Ohid Yaqub & Stephanie Diepeveen (2010), Intellectual Property and Developing Countries: A review of the literature, Technical Reports, TR-804-IPO, Santa Monica: RAND Corporation. Open Google Scholar DOI: 10.5771/9783845262321
  425. Hausmann, Ricardo & Bailey Klinger (2007), The Structure of the Product Space and the Evolution of Comparative Advantage, CID Working Paper, No. 146, Cambridge: Center for International Development at Harvard University. Open Google Scholar DOI: 10.5771/9783845262321
  426. Hein, Wolfgang (1998), Unterentwicklung – Krise der Peripherie: Phänomene, Theorien, Strategien, Opladen: Leske + Budrich. Open Google Scholar DOI: 10.5771/9783845262321
  427. Hemmer, Hans-Rimbert & Rainer Wilhelm (2001), Neue Hoffnung für Entwicklungsländer? Entwicklungspolitische Implikationen endogener Wachstumstheorien, in: Reinold E. Thiel (Hrsg.), Neue Ansätze zur Entwicklungstheorie, Bonn: Deutsche Stiftung für internationale Entwicklung, 249-258. Open Google Scholar DOI: 10.5771/9783845262321
  428. Herring, Ronald J. (1999), Embedded Particularism: India's Failed Devleopmental State, in: Meredith Woo-Cumings (Hrsg.), The Developmental State, Ithaca: Cornell University Press, 306-332. Open Google Scholar DOI: 10.5771/9783845262321
  429. Herrmann, Margaret G. (2008), Content Analysis, in: Audie Klotz & Deepa Prakash (Hrsg.), Qualitative Methods in International Relations: A Pluralist Guide, Basingstoke: Palgrave Macmillan, 151-167. Open Google Scholar DOI: 10.5771/9783845262321
  430. Hirschman, Albert O. (1958), The Strategy of Economic Development, New Haven: Yale University Press. Open Google Scholar DOI: 10.5771/9783845262321
  431. Hobday, Michael (1995), Innovation in East Asia: The Challenge to Japan, Aldershot: Edward Elgar. Open Google Scholar DOI: 10.5771/9783845262321
  432. Hoffmann, Jean (2005), Generics Growth in the USA and the EU: The Role of India, Journal of Generic Medicines, 3(1), 7-19. Open Google Scholar DOI: 10.5771/9783845262321
  433. Hollingsworth, J. Rogers & Robert Boyer (Hrsg.) (1997), Contemporary Capitalism: The Embeddedness of Institutions, Cambridge: Cambridge University Press. Open Google Scholar DOI: 10.5771/9783845262321
  434. Hooda, Shailender Kumar (2013), Changing Pattern of Public Expenditure on Health in India: Issues and Challenges, Working Paper Series, No. 01, New Delhi: ISID-PHFI Collaborative Research Centre Institute for Studies in Industrial Development. Open Google Scholar DOI: 10.5771/9783845262321
  435. Horner, Rory (2013), The Impact of Patents on Innovation, Technology Transfer and Health: A Pre- and Post-TRIPs Analysis of India's Pharmaceutical Industry, New Political Economy, DOI:10.1080/13563467.2013.796446. Open Google Scholar DOI: 10.5771/9783845262321
  436. Howells, Jeremy (1999), Regional systems of innovation?, in: Daniele Archibugi et al. (Hrsg.), Innovation Policy in a Global Economy, Cambridge: Cambridge University Press, 67-93. Open Google Scholar DOI: 10.5771/9783845262321
  437. HP (2012), CSIR and HP announce the launch of a rapidly deployable and fully integrated cloud-enabled eHealth Centre, 11.12.12. Open Google Scholar DOI: 10.5771/9783845262321
  438. Hubaceka, Klaus, Dabo Guana & Anamika Baruaa (2007), Changing lifestyles and consumption patterns in developing countries: A scenario analysis for China and India, Futures, 39(9), 1084-1096. Open Google Scholar DOI: 10.5771/9783845262321
  439. Huibo, Zhong & Zheng Bingwen (2011), Comparison of Government Functions of BRIC in «National Innovation System”: From the Degree of Homoplasy and Embeddedness, in: Li Yang (Hrsg.), BRICs & the global transformation: Considerations on the BRIC Summit of Think Tanks in Brasilia, Reading: Social Sciences Academic Press, 139-165. Open Google Scholar DOI: 10.5771/9783845262321
  440. Humphrey, John & Hubert Schmitz (2000), Governance and Upgrading: Linking Industrial Cluster and Global Value Chain Research, Institute of Development Studies, IDS Working Paper 120, Brighton: University of Sussex,. Open Google Scholar DOI: 10.5771/9783845262321
  441. Humphrey, John & Hubert Schmitz (2002), How does insertion in global value chains affect upgrading in industrial clusters?, Regional Studies, 36(9), 1017-1027. Open Google Scholar DOI: 10.5771/9783845262321
  442. IBGE (2010), Pesquisa de Inovação Tecnológica, Instituto Brasileiro de Geografia e Estatística, Ministério do Planejamento, Orçamento e Gestão, Rio de Janeiro. Open Google Scholar DOI: 10.5771/9783845262321
  443. ICIS news (2003), Matrix rejects Lundbeck's DKr300m offer to halt production, 14.02.03. Open Google Scholar DOI: 10.5771/9783845262321
  444. ICRA (2011), CRAMS India: Overview & Outlook, Juni 2011, <http://www.icra.in/ Open Google Scholar DOI: 10.5771/9783845262321
  445. Files/Articles/CRAMS%20Note,%20Overview%20and%20Outlook.pdf>. Open Google Scholar DOI: 10.5771/9783845262321
  446. IMF (2003), World Economic Outlook April 2003: Growth and Institutions, Washington, D.C.: International Monetary Fund. Open Google Scholar DOI: 10.5771/9783845262321
  447. India Daily (2007), A new trend in emerging nations - Brazil opts for Indian generic drug ignoring US pharmaceutical giant Merck’s patent on AIDS drug Efavirenz, 06.05.07. Open Google Scholar DOI: 10.5771/9783845262321
  448. IP Health (2006), Brazil consideration of compulsory license of Viread patents, 22.12.06. Open Google Scholar DOI: 10.5771/9783845262321
  449. IP Health (2012), Ip-health Digest, Ip-health Digest, 29(16). Open Google Scholar DOI: 10.5771/9783845262321
  450. IP Tango (2009), Brazilian PPPs in the Pharma Industry, 06.04.09. Open Google Scholar DOI: 10.5771/9783845262321
  451. IP Tango (2011), Brazil and the antidepressant market: changing the mood, 23.08.11. Open Google Scholar DOI: 10.5771/9783845262321
  452. IP Watch (2008), US, Indian HIV/AIDS Drug Rulings Could Reverberate In Brazil, 04.07.08. Open Google Scholar DOI: 10.5771/9783845262321
  453. IP Watch (2010), Inside Views: Big Pharma Stranglehold: Thwarting India As Independent Maker Of Blockbuster HIV Drugs?, 28.10.10. Open Google Scholar DOI: 10.5771/9783845262321
  454. IP Watch (2012), India Grants First Compulsory Licence, For Bayer Cancer Drug, 12.03.2012. Open Google Scholar DOI: 10.5771/9783845262321
  455. IP Watch (2013), Inside Views: The Novartis Decision: A Tale Of Developing Countries, IP, And The Role Of The Judiciary, 15.04.13. Open Google Scholar DOI: 10.5771/9783845262321
  456. IPR (2010), Indian President Patil speaks at Inauguration of National Seminar on Recent Trends in Pharmacy Education and Practice, New Delhi: The Office of President of India, 09.07.10. Open Google Scholar DOI: 10.5771/9783845262321
  457. Jaffe, Adam B. & Josh Lerner (2004), Innovation and Its Discontents: How Our Broken Patent System is Endangering Innovation and Progress, and What to Do About It, Princeton: Princeton University Press. Open Google Scholar DOI: 10.5771/9783845262321
  458. Jahn, Detlef (2005), Fälle, Fallstricke und die komparative Methode in der vergleichenden Politikwissenschaft, in: Sabine Kropp & Michael Minkenberg (Hrsg.), Vergleichen in der Politikwissenschaft, Wiesbaden: VS Verlag für Sozialwissenschaften, 55-75. Open Google Scholar DOI: 10.5771/9783845262321
  459. Jeffrey, Roger & MR Santhosh (2009), Architecture of Drug Regulation in India. What are the Barriers to Regulatory Reform?, Journal of Health Studies, 2(1-3), 13-31. Open Google Scholar DOI: 10.5771/9783845262321
  460. Johnson, Björn, Charles Edquist & Bengt-Åke Lundvall (2003), Economic Development and the National System of Innovation Approach, 1st GLOBELICS Conference: Innovation Systems and Development Strategies for the Third Millennium, Rio de Janeiro, 03.-06. November. Open Google Scholar DOI: 10.5771/9783845262321
  461. Johnson, Björn & Bengt-Åke Lundvall (2003), Promoting innovation systems as a response to the globalizing learning economy, in: José E. Cassiolato et al. (Hrsg.), Systems of Innovation: Evidence from Brazil, Cheltenham: Edward Elgar, 141-184. Open Google Scholar DOI: 10.5771/9783845262321
  462. Joyce, Joseph P. & Ilan Noy (2005), The IMF and the Liberalization of Capital Flows, East-West Center Working Papers, Economics Series, Honolulu: East-West Center,. Open Google Scholar DOI: 10.5771/9783845262321
  463. Juma, Calestous et al. (2001), Global governance of technology: meeting the needs of developing countries, International Journal of Technology Management, 22(7/8), 629-655. Open Google Scholar DOI: 10.5771/9783845262321
  464. Kaiser Health News (2005), Brazil Requests Voluntary Licensing for AIDS Drugs To Treat More Patients, Reduce Costs of Importing Patented Drugs, 16.03.05. Open Google Scholar DOI: 10.5771/9783845262321
  465. Kale, Dinar & Steve Little (2007), From Imitation to Innovation: The Evolution of R&D Capabilities and Learning Processes in the Indian Pharmaceutical Industry, Technology Analysis & Strategic Management, 19(5), 589-609. Open Google Scholar DOI: 10.5771/9783845262321
  466. Kapczynski, Amy (2009), Harmonization and Its Discontents: A case Study of TRIPS Implementation in India's Pharmaceutical Sector, California Law Review, 97, 1571-1650. Open Google Scholar DOI: 10.5771/9783845262321
  467. Kapczynski, Amy (2013), Engineered in India — Patent Law 2.0, The New England Journal of Medicine, 369(6), 497-499. Open Google Scholar DOI: 10.5771/9783845262321
  468. Kaplinsky, Raphael (2000), Globalisation and Unequalisation: What Can Be Learned from Value Chain Analysis?, Journal of Development Studies, 37(2), 117-146. Open Google Scholar DOI: 10.5771/9783845262321
  469. KEI (2012), KEI Statement on India's granting of compulsory license to patents on cancer drug sorafenib (NATCO Vs. BAYER), James Love's blog, Knowledge Ecology International, 12.03.12. Open Google Scholar DOI: 10.5771/9783845262321
  470. Kessler, Eric H. & Alok K. Chakrabarti (1996), Innovation Speed: A Conceptual Model of Context, Antecedents, and Outcomes, The Academy of Management Review, 21(4), 1143-1191. Open Google Scholar DOI: 10.5771/9783845262321
  471. Khader, Feroz Ali (2007), The Law of Patents - With a Special Focus on Pharmaceuticals in India, New Delhi: LexisNexis Butterworths. Open Google Scholar DOI: 10.5771/9783845262321
  472. Kim, Linsu (1997), Imitation to Innovation: the Dynamics of Korea’s Technological Learning, Boston: Harvard Business School Press. Open Google Scholar DOI: 10.5771/9783845262321
  473. Kim, Linsu (1999), Learning And Innovation In Economic Development, Cheltenham: Edward Elgar. Open Google Scholar DOI: 10.5771/9783845262321
  474. King, Gary, Robert O. Keohane & Sidney Verba (1994), Designing Social Inquiry: Scientific Inference in Qualitative Research, Princeton: Princeton University Press. Open Google Scholar DOI: 10.5771/9783845262321
  475. Kiran, Ravi & Sunita Mishra (2009), Changing Pragmatics of the Indian Pharmaceutical Industry in the Pre and Post TRIPS Period, International Journal of Business and Management, 4(9), 206-220. Open Google Scholar DOI: 10.5771/9783845262321
  476. Klein, Helena Espellet, Lia Hasenclever & Carlos José Saldanha Machado (2011), Regulação e Difusão de Tecnologias e sua Influência na Capacitação Tecnológica em Saúde Dos Países em Desenvolvimento, Revista Brasileira de Ciência, Tecnologia e Sociedade, 2(2), 130-149. Open Google Scholar DOI: 10.5771/9783845262321
  477. Koeller, Priscila & José Luis Gordon (2013), Brazil, in: Mario Scerri & Helena M. M. Lastres (Hrsg.), The Role of the State, New Delhi: Routledge, 23-79. Open Google Scholar DOI: 10.5771/9783845262321
  478. Korzeniewicz, Roberto Patricio (2012), Trends in World Income Inequality and the ‘Emerging Middle, European Journal of Development Research, 24(2), 205-222. Open Google Scholar DOI: 10.5771/9783845262321
  479. Krishna, V. V. (2013), India, in: Mario Scerri & Helena M. M. Lastres (Hrsg.), The Role of the State, New Delhi: Routledge, 138-187. Open Google Scholar DOI: 10.5771/9783845262321
  480. Krugman, Paul (2009), How Did Economists Get It So Wrong?, The New York Times Sunday Magazine, 06.09.09. Open Google Scholar DOI: 10.5771/9783845262321
  481. Kuckartz, Udo (2009), Inhaltsanalyse, in: Bettina Westle (Hrsg.), Methoden der Politikwissenschaft, Baden-Baden: Nomos, 334-344. Open Google Scholar DOI: 10.5771/9783845262321
  482. Kuhrt, Nicola (2012), Klinische Studien in Indien: Erst der Test, dann die Moral, Spiegel Online, 09.05.2012. Open Google Scholar DOI: 10.5771/9783845262321
  483. Kumar, Nagesh (1998), Technology Generation and Technology Transfer in the World Economy, Science Technology Society, 3, 265-306. Open Google Scholar DOI: 10.5771/9783845262321
  484. Kurtz, Marcus J. & Sarah M. Brooks (2008), Embedding Neoliberal Reform in Latin America, World Politics, 2(1), 231-280. Open Google Scholar DOI: 10.5771/9783845262321
  485. Lachmann, Werner (2004), Entwicklungspolitik. Band 1: Grundlagen, 1, München: Oldenbourg. Open Google Scholar DOI: 10.5771/9783845262321
  486. Laforgia, Francesco, Fabio Montobbio & Luigi Orsenigo (2009), IPRs and Technological Development in Pharmaceuticals. Who is patenting what in Brazil after TRIPS?, in: Neil Weinstock Netanel (Hrsg.), The Development Agenda: Global Intellectual Property and Developing Countries, New York: Oxford University Press, 293-319. Open Google Scholar DOI: 10.5771/9783845262321
  487. Lal, Harivansh (1990), Drugs industry, social responsibility, and the multinationals, New Delhi: Commonwealth Publishers. Open Google Scholar DOI: 10.5771/9783845262321
  488. Lall, Sanjaya (1992), The Role of Technology in Economic Development, in: Simon Teitel (Hrsg.), Towards a New Development Strategy for Latin America: Pathways from Hirschman's Thought, Washington, D.C.: John Hopkins University Press, 169-218. Open Google Scholar DOI: 10.5771/9783845262321
  489. Lall, Sanjaya (1998), Technological capabilities in emerging Asia, Oxford Agrarian Studies, 26(2), 213-243. Open Google Scholar DOI: 10.5771/9783845262321
  490. Lall, Sanjaya (1999), India's Manufactured Exports: Comparative Structure and Prospects, World Development, 27(10), 1769-1786. Open Google Scholar DOI: 10.5771/9783845262321
  491. Landes, W. & R. Posner (2003), The economic structure of intellectual property law, Cambridge: The Belkup Press of Harvard University Press. Open Google Scholar DOI: 10.5771/9783845262321
  492. Landesmann, Michael & Robert Stehrer (2004), Global Growth Processes: Technology Diffusion, Catching-up and Effective Demand, wiiw Working Paper, No. 26, Wien: Wiener Institut für Internationale Wirtschaftsvergleiche, Januar. Open Google Scholar DOI: 10.5771/9783845262321
  493. Lastres, Helena Maria Martins, José E. Cassiolato & Maria Lucia Maciel (2003), Systems of innovation for development in the knowledge era: an introduction, in: José E. Cassiolato et al. (Hrsg.), Systems of Innovation and Development, Evidence from Brazil, Cheltenham: Edward Elgar, 1-34. Open Google Scholar DOI: 10.5771/9783845262321
  494. Lettington, Robert & Mita Manek (1998), "Pandora's Box": TRIPS Article 27 (3) (b) and the CBD, <http://www.iatp.org/files/Pandoras_Box_TRIPs_Article_ Open Google Scholar DOI: 10.5771/9783845262321
  495. 273b_and_the_CBD.htm>. Open Google Scholar DOI: 10.5771/9783845262321
  496. Levin, Richard C. et al. (1987), Appropriating the Returns from Industrial Research and Development, Brookings Papers on Economic Activity (3: Microeconomics), 783-831. Open Google Scholar DOI: 10.5771/9783845262321
  497. Lewis, W. Arthur (1954), Economic Development with Unlimited Supplies of Labour, The Manchester School, 22(2), 139-191. Open Google Scholar DOI: 10.5771/9783845262321
  498. Li, Xuan (2008), The Impact of Higher Standards in Patent Protection for Pharmaceutical Industries under the TRIPS Agreement: A Comparative Study of China and India, UNU-WIDER Research Paper, No. 36, Helsinki: UNU World Institute for Development Economics Research,. Open Google Scholar DOI: 10.5771/9783845262321
  499. Lijphart, Arend (1971), Comparative politics and the comparative method, American Political Science Review, 65(3), 682-693. Open Google Scholar DOI: 10.5771/9783845262321
  500. Lijphart, Arend (1975), The Comparable-Cases Strategy in Comparative Research, Comparative Political Studies, 8(2), 158-177. Open Google Scholar DOI: 10.5771/9783845262321
  501. Lind, Hans-Günter & Pedro Gouveia (2012), The Life Sciences Industry in Brazil, Working Paper, Leipzig: Fraunhofer-Zentrum für Mittel- und Osteuropa. Open Google Scholar DOI: 10.5771/9783845262321
  502. Lipietz, Alain (1987), Mirages and Miracles: The Crisis of Global Fordism, London: Verso. Open Google Scholar DOI: 10.5771/9783845262321
  503. List, Friedrich (1841), Das Nationale System der Politischen Ökonomie, Basel: Kyklos. Open Google Scholar DOI: 10.5771/9783845262321
  504. Liu, Xielin & Steven White (2001), Comparing innovation systems: a framework and application to China’s transitional context, Research Policy, 30(7), 1091-1114. Open Google Scholar DOI: 10.5771/9783845262321
  505. Livemint (2008), Natco withdraws plea on making patented cancer drugs, 28.09.08. Open Google Scholar DOI: 10.5771/9783845262321
  506. Livemint (2009), CSIR lab in second licensing deal with US pharma company, 22.02.09. Open Google Scholar DOI: 10.5771/9783845262321
  507. Livemint (2012), Bayer asked to give cost data, 13.01.12. Open Google Scholar DOI: 10.5771/9783845262321
  508. Love, James Packard (2007), Recent examples of compulsory licensing of patents, KEI Research Note, No. 2, Washington, D.C.: Knowledge Ecology International. Open Google Scholar DOI: 10.5771/9783845262321
  509. Lu, Bingbin (2011), Best Mode Disclosure for Patent Applications: An International and Comparative Perspective, Journal of Intellectual Property Rights, 16(5), 409-417. Open Google Scholar DOI: 10.5771/9783845262321
  510. Lundvall, Bengt-Åke (1992), National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning, London: Pinter. Open Google Scholar DOI: 10.5771/9783845262321
  511. Lundvall, Bengt-Åke (2007), National Innovation Systems: Analytical Concept and Development Tool, Industry and Innovation, 14(1), 95-119. Open Google Scholar DOI: 10.5771/9783845262321
  512. Lundvall, Bengt-Åke, Patarapong Intarakumnerd & Jan Vang (2006), Asia’s Innovation Systems in Transition: An Introduction, in: Bengt-Åke Lundvall et al. (Hrsg.), Asia’s Innovation Systems in Transition, Cheltenham: Edward Elgar, 1-20. Open Google Scholar DOI: 10.5771/9783845262321
  513. Lundvall, Bengt-Åke et al. (2002), National systems of production, innovation and competence building, Research Policy, 31, 213-231. Open Google Scholar DOI: 10.5771/9783845262321
  514. Lundvall, Bengt-Åke et al. (2009), Innovation System Research and Developing Countries, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 1-30. Open Google Scholar DOI: 10.5771/9783845262321
  515. Lütz, Susanne (2003), Governance in der politischen Ökonomie, MPIfG Discussion Paper, No. 5, Köln: Max-Planck-Institut für Gesellschaftsforschung. Open Google Scholar DOI: 10.5771/9783845262321
  516. Mahajan, Madhur Mohit (2011), The Emergence of New R&D Paradigms in the Indian Pharmaceutical Industry: Post TRIPS Period, Journal of Intellectual Property Rights, 16(4), 321-329. Open Google Scholar DOI: 10.5771/9783845262321
  517. Mahoney, James (2000), Path dependence in historical sociology, Theory and Society, 29(4), 507-548. Open Google Scholar DOI: 10.5771/9783845262321
  518. Malerba, Franco (2005), Sectoral Systems: How and Why Innovation Differs across Sectors, in: Jan Fagerberg et al. (Hrsg.), The Oxford Handbook of Innovation, Oxford: Oxford University Press, 380-406. Open Google Scholar DOI: 10.5771/9783845262321
  519. Malerba, Franco (2006), Catch up in different sectoral systems - some introductory remarks, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  520. Malerba, Franco & Richard Nelson (2011), Learning and catching up in different sectoral systems: evidence from six industries, Industrial and Corporate Change, 20(6), 1645-1675. Open Google Scholar DOI: 10.5771/9783845262321
  521. Mani, Sunil (2006a), The incremental innovator versus the trader contrast between the sectoral system of innovation of the Indian pharmaceutical and telecommunication industries, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  522. Mani, Sunil (2006b), The Sectoral System of Innovation of Indian Pharmaceutical Industry, Working Paper, No. 382, Thiruvananthapuram: Centre for Development Studies. Open Google Scholar DOI: 10.5771/9783845262321
  523.   Open Google Scholar DOI: 10.5771/9783845262321
  524. Manikandan, A.D. (2006), Performance of Foreign Multinationals and Domestic Companies in India since Liberalisation: A Comparative Study, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  525. Marcellin, Sherry S. (2010), The Political Economy of Pharmaceutical Patents: US Sectional Interests and the African Group at the WTO, Farnham: Ashgate. Open Google Scholar DOI: 10.5771/9783845262321
  526. Maskus, Keith E. (2000), Intellectual Property Rights in the Global Economy, Washington, D.C.: Institute for International Economics. Open Google Scholar DOI: 10.5771/9783845262321
  527. May, Christopher (2004), Cosmopolitan legalism meets "thin community": problems in the global governance of intellectual property, Government and Opposition, 39(3), 393-422. Open Google Scholar DOI: 10.5771/9783845262321
  528. Mayntz, Renate (2002), Zur Theoriefähigkeit makro-sozialer Analysen, in: Renate Mayntz (Hrsg.), Akteure - Mechanismen - Modelle: Zur Theoriefähigkeit makro-sozialer Analysen, Frankfurt am Main: Campus, 7-43. Open Google Scholar DOI: 10.5771/9783845262321
  529. Mayntz, Renate & Fritz W. Scharpf (1995), Der Ansatz des akteurzentrierten Institutionalismus, in: Renate Mayntz & Fritz W. Scharpf (Hrsg.), Gesellschaftliche Selbstregelung und politische Steuerung, Frankfurt am Main: Campus, 39-72. Open Google Scholar DOI: 10.5771/9783845262321
  530. Mayntz, Renate et al. (2005), Globale Strukturen und deren Steuerung: Auswertung der Ergebnisse eines Förderprogramms der Volkswagen Stiftung, Forschungsbericht aus dem MPIfG, MPIfG Working Paper No. 5, Köln: Max-Planck-Institut für Gesellschaftsforschung. Open Google Scholar DOI: 10.5771/9783845262321
  531. Mazumdar, Mainak (2013), Performance of Pharmaceutical Companies in India: A Critical Analysis of Industrial Structure, Firm Specific Resources, and Emerging Strategies, Heidelberg: Physica Verlag. Open Google Scholar DOI: 10.5771/9783845262321
  532. MCTI (2013), Resultado Após Análises dos Recursos, Chamada Pública MCTI / FINEP / Ação Transversal – Inova Empresa – PNI/Parques Tecnológicos 02/2013, Brasília. Open Google Scholar DOI: 10.5771/9783845262321
  533. Meckstroth, Theodore W. (1975), «Most Different Systems” and «Most Similar Systems”: A Study in the Logic of Comparative Inquiry, Comparative Political Studies, 8(2), 132-157. Open Google Scholar DOI: 10.5771/9783845262321
  534. Menghaney, Leena (2012), India’s patent law on trial, BMJ Group Blogs, 27.09.12. Open Google Scholar DOI: 10.5771/9783845262321
  535. Menghaney, Leena (2013), ‘Drop the Case’: Campaigning against Novartis, Economic & Political Weekly, 48(32), 52-54. Open Google Scholar DOI: 10.5771/9783845262321
  536. Meuser, Michael & Ulrike Nagel (2009), Experteninterview und der Wandel der Wissensproduktion, in: Alexander Bogner et al. (Hrsg.), Experteninterviews: Theorien, Methoden, Anwendungsfelder, Wiesbaden: VS Verlag für Sozialwissenschaften, 35-60. Open Google Scholar DOI: 10.5771/9783845262321
  537. Mill, John Stuart (1884), A system of logic, ratiocinative and inductive: being a connected view of the principles of evidence and the methods of scientific investigation London: Routledge. Open Google Scholar DOI: 10.5771/9783845262321
  538. Milstien, Julie B., Patrick Gaulé & Miloud Kaddar (2007), Access to Vaccine Technologies in Developing Countries: Brazil and India, Vaccine, 25(44), 7610-7619. Open Google Scholar DOI: 10.5771/9783845262321
  539. Miramontes, Eduardo Zepeda (2006), The Segusino Cluster: Boom and Bust in Furniture Exports, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 143-174. Open Google Scholar DOI: 10.5771/9783845262321
  540. Mkandawire, Thandika (2007), Transformative Social Policy and Innovation in Developing Countries, The European Journal of Development Research, 19(1), 13-29. Open Google Scholar DOI: 10.5771/9783845262321
  541. MoCF (2011), National Pharmaceuticals Pricing Policy 2011, Department of Pharmaceuticals, Government of India, Ministry of Chemicals & Fertilizers, New Delhi. Open Google Scholar DOI: 10.5771/9783845262321
  542. MoCF (2012), Annual Report 2011-12, Department of Pharmaceuticals, Government of India, Ministry of Chemicals & Fertilizers, New Delhi. Open Google Scholar DOI: 10.5771/9783845262321
  543. MoCF (2013), Drug Price Control Order, Department of Pharmaceuticals, Government of India, Ministry of Chemicals & Fertilizers, New Delhi. Open Google Scholar DOI: 10.5771/9783845262321
  544. MoCI (2004), Kamal Nath's Statement on the Ordinance Relating to Patents (Third) Amendment, Press Information Bureau, Government of India, Ministry of Commerce & Industry, 27.12.04. Open Google Scholar DOI: 10.5771/9783845262321
  545. MoCI (2008), Strategy for Increasing Exports of Pharmaceutical Products: Report of the Task Force, Department of Commerce, Government of India, Ministry of Commerce and Industry, New Delhi. Open Google Scholar DOI: 10.5771/9783845262321
  546. Morel, Carlos et al. (2005), Health Innovation Networks to Help Developing Countries Address Neglected Diseases, Science, 309(5733), 401-404. Open Google Scholar DOI: 10.5771/9783845262321
  547. Morrison, Andrea (2008), Gatekeepers of Knowledge within Industrial Districts: Who They Are, How They Interact, Regional Studies, 42(6), 817-835. Open Google Scholar DOI: 10.5771/9783845262321
  548. Morrison, Andrea, Carlo Pietrobelli & Roberta Rabellotti (2008), Global Value Chains and Technological Capabilities: A Framework to Study Learning and Innovation in Developing Countries, Oxford Development Studies, 36(1), 39-58. Open Google Scholar DOI: 10.5771/9783845262321
  549. MoST (2011), Youngsters Should Join Innovative Scientific Research to Secure World Leadership: Deshmukh, Be Globally Competitive to have Cutting Edge Advantage: Ashwani Kumar, Press Information Bureau, Government of India, Ministry of Science & Technology, 26.09.11. Open Google Scholar DOI: 10.5771/9783845262321
  550. Mowery, David C. & Joanne E. Oxley (1995), Inward Technology Transfer and Competitiveness: The Role of National Innovation Systems, Cambridge Journal of Economics, 19(1), 67-93. Open Google Scholar DOI: 10.5771/9783845262321
  551. Mowery, David & Nathan Rosenberg (1998), Paths of Innovation: Technological Change in 20th-Century America, Cambridge: Cambridge University Press. Open Google Scholar DOI: 10.5771/9783845262321
  552. MPP (2011), Second Amendment to License Agreement, 14.11.11. Open Google Scholar DOI: 10.5771/9783845262321
  553. MPP (2013), Licences in the Pool, Geneva: Medicines Patent Pool. Open Google Scholar DOI: 10.5771/9783845262321
  554. MS (2008), Pesquisa em saúde no Brasil, Revista de Saúde Pública, 42(4), 773-775. Open Google Scholar DOI: 10.5771/9783845262321
  555. MS (2010), Targets and Commitments made by Member-States at the United Nations General Assembly Special Session on HIV/AIDS, Brazilian Response 2008-2009 Country Progress Report, Brasília: Brazilian Ministry of Health, Health Surveillance Secretariat, STD, AIDS and Viral Hepatitis Department, März. Open Google Scholar DOI: 10.5771/9783845262321
  556. MS (2012), Estratégia para Incentivo da Produção de Fármacos no Brasil, 6º Encontro Nacional de Inovação em Fármacos e Medicamentos, Brasília. Open Google Scholar DOI: 10.5771/9783845262321
  557. MS (2013a), Parcerias de Desenvolvimento Produtivo, Coordenação-Geral de Base Química e Biotecnológica Departamento do Complexo Indústrial e Inovação em Saúde, Brasília: Ministerio da Saúde, <http://portal.saude.gov.br/portal/ Open Google Scholar DOI: 10.5771/9783845262321
  558. arquivos/pdf/PDP_Plano_de_desenvolvimento.pdf>. Open Google Scholar DOI: 10.5771/9783845262321
  559. MS (2013b), Relação Nacional de Medicamentos Essenciais Brasília, 08.08.13, <http://portal.saude.gov.br/portal/arquivos/pdf/rename_anexos_versao_08_08_2013.pdf>. Open Google Scholar DOI: 10.5771/9783845262321
  560. MSCI ESG Research (2012), Methodology Report 2012: Stakeholder Review, Haarlem: Access to Medicine Foundation, May 2012, <http://www.accesstomedicine Open Google Scholar DOI: 10.5771/9783845262321
  561. index.org/sites/www.accesstomedicineindex.org/files/2012_Methodology_Report_-_Stakeholder_Review_-_May_2012.pdf>. Open Google Scholar DOI: 10.5771/9783845262321
  562. MSF (2011), India Rejects Patents for Two Key AIDS Drugs, Geneva, 07.01.11, <http://www.msfaccess.org/about-us/media-room/press-releases/india-re Open Google Scholar DOI: 10.5771/9783845262321
  563. jects-patents-two-key-aids-drugs>. Open Google Scholar DOI: 10.5771/9783845262321
  564. MST (2013), Science, Technology and Innovation Policy 2013, New Delhi: Government of India: Ministry of Science and Technology. Open Google Scholar DOI: 10.5771/9783845262321
  565. Mugabe, John O. (2005), Health Innovation Systems in Developing Countries: Strategies for Building Scientific and Technological Capacities, Background Paper Prepared for the Commission on Intellectual Property, Innovation and Public Health, Geneva: World Health Organization,. Open Google Scholar DOI: 10.5771/9783845262321
  566. NACO (2013), Annual Report 2012-13, National AIDS Control Organisation Department of AIDS Control, Government of India, Ministry of Health & Family Welfare, New Delhi. Open Google Scholar DOI: 10.5771/9783845262321
  567. Nair, Gopakumar G. (2008a), Impact of TRIPS on Indian Pharmaceutical Industry, Journal of Intellectual Property Rights, 13, 432-441. Open Google Scholar DOI: 10.5771/9783845262321
  568. Nair, MD (2008b), Compromizing TRIPS: Brazil's Approach to Tackle the HIV/AIDS Imbroglio, Journal of Intellectual Property Rights, 13, 456-463. Open Google Scholar DOI: 10.5771/9783845262321
  569. Nassif, André (2007), National Innovation System and Macroeconomic Policies: Brazil and India in Comparative Perspective, Discussion Papers, No. 184, Geneva: United Nations Conference on Trade and Development. Open Google Scholar DOI: 10.5771/9783845262321
  570. Neeraj, Shekhar Sumeet (2011a), Indian Pharmaceuticals Industry: A comprehensive review report, Visakhapatnam, 05. Mai, <http://de.scribd.com/doc/54681742/Best-Pharma-Industry-Report-2011-India>. Open Google Scholar DOI: 10.5771/9783845262321
  571. Neeraj, Sumeet Shekhar (2011b), India Pharmaceutical-Industry as an Export Sector, Visakhapatnam, 17. Januar, <http://www.scribd.com/doc/48571412/ Open Google Scholar DOI: 10.5771/9783845262321
  572. Indian-Pharmaceutical-Export-Industry>. Open Google Scholar DOI: 10.5771/9783845262321
  573. Neeraj, Sumeet Shekhar (2011c), Indian Pharmaceuticals Export Industry: Contemporary scenario, critical analysis & future trends, Visakhapatnam, 05. Oktober, <http://de.scribd.com/doc/68899825/Latest-Best-Rated-Pharma-Industry-Re Open Google Scholar DOI: 10.5771/9783845262321
  574. port-India-2011-2012>. Open Google Scholar DOI: 10.5771/9783845262321
  575. Nelson, Richard R. (1993), National Innovation Systems: A Comparative Analysis, New York: Oxford University Press. Open Google Scholar DOI: 10.5771/9783845262321
  576. Nelson, Richard R. & Sidney G. Winter (1982), An Evolutionary Theory of Economic Change, Cambridge: Harvard University Press. Open Google Scholar DOI: 10.5771/9783845262321
  577. Niosi, Jorge (2002), National systems of innovations are «x-efficient” (and x-effective): Why some are slow learners, Research Policy, 31(2), 291-302. Open Google Scholar DOI: 10.5771/9783845262321
  578. Niosi, Jorge (2011), Building innovation systems: an introduction to the special section, Industrial and Corporate Change, 20(6), 1637-1643. Open Google Scholar DOI: 10.5771/9783845262321
  579. Niosi, Jorge & Bertrand Bellon (1994), The global interdependence of national innovation systems: Evidence, limits, and implications, Technology in Society, 16(2), 173-197. Open Google Scholar DOI: 10.5771/9783845262321
  580. Niosi, Jorge et al. (1993), National Systems of Innovation: In Search of a Workable Concept, Technology in Society, 15(2), 207-227. Open Google Scholar DOI: 10.5771/9783845262321
  581. Nohlen, Dieter (2004), Vergleichende Methode, in: Dieter Nohlen & Rainer-Olaf Schultze (Hrsg.), Lexikon der Politikwissenschaft, 2. Auflage, München: Beck. Open Google Scholar DOI: 10.5771/9783845262321
  582. Nohlen, Dieter & Rainer-Olaf Schultze (2002), Lexikon der Politikwissenschaft, 2. Auflage, München: Beck Verlag. Open Google Scholar DOI: 10.5771/9783845262321
  583. Nortec (oJ), Portfólio Mercado Exportação, <http://www.nortecquimica.com.br/ Open Google Scholar DOI: 10.5771/9783845262321
  584. produtos/2/portfolio-mercado-exportacao.html>. Open Google Scholar DOI: 10.5771/9783845262321
  585. Nowotny, Helga, Peter Scott & Michael Gibbons (2001), Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty, Cambridge: Polity Press. Open Google Scholar DOI: 10.5771/9783845262321
  586. NRDC (2011), Annual Report 2010-11, New Delhi. Open Google Scholar DOI: 10.5771/9783845262321
  587. Nugent, Rachel (2008), Chronic Diseases in Developing Countries: Health and Economic Burdens, Annals of the New York Academy of Sciences, 1136, 70-79. Open Google Scholar DOI: 10.5771/9783845262321
  588. Nunnenkamp, Peter (1998), Lateinamerika nach der verlorenen Dekade - eine Zwischenbilanz der Reformen, Kieler Diskussionsbeiträge, Kiel: Institut für Weltwirtschaft,. Open Google Scholar DOI: 10.5771/9783845262321
  589. NZZ (2013), Patentschutz in Indien: Roche entschärft Politikum, Neue Zürcher Zeitung, 16.08.13. Open Google Scholar DOI: 10.5771/9783845262321
  590. Obinger, Herbert (2009), Vergleichende Politikanalyse: Eine Einführung in makro-quantitative und makro-qualitative Methoden, in: Klaus Schubert & Nils C. Bandelow (Hrsg.), Lehrbuch der Politikfeldanalyse 2.0, München: Oldenbourg, 221-244. Open Google Scholar DOI: 10.5771/9783845262321
  591. Octaviani, Alessandro (2010), Biotechnology in Brazil: Promoting Open Innovation, in: Lea Shaver (Hrsg.), Access to Knowledge in Brazil: New Research on Intellectual Property, Innovation and Development, London: Bloomsbury Academic, 79-102. Open Google Scholar DOI: 10.5771/9783845262321
  592. Oguamanam, Chidi (2004), Localizing Intellectual Property in the Globalization Epoch: The Integration of Indigenous Knowledge, Indiana Journal of Global Legal Studies, 11(2), 135-169. Open Google Scholar DOI: 10.5771/9783845262321
  593. Ohly, Christopher (2012), The New India Guidelines On Similar Biologics Regulatory and Market Authorization Requirements, 08.10.12, <http://spicyip.com/docs/ Open Google Scholar DOI: 10.5771/9783845262321
  594. The-New-India-Biosimilar-Guidelines-(End-Notes)(Final)-10.08.12.pdf>. Open Google Scholar DOI: 10.5771/9783845262321
  595.   Open Google Scholar DOI: 10.5771/9783845262321
  596. Oliveira, Maria Auxiliadora et al. (2006 ), Protección de Patentes Farmacéuticas en Brasil: Quien se Beneficia?, in: Jorge A. Bermudez & Maria Auxiliadora Oliveira (Hrsg.), La Propriedad Intelectual En El Contexto Del Acuerdo De La OMC Sobre Los ADPIC: Desafíos Para La Salud Pública, Rio de Janeiro: Centro Colborado de OPS/OMS en Políticas Farmacéuticas, Escuela National de Salud Pública Sergio Arouca, Fundación Oswaldo Cruz, 175-191. Open Google Scholar DOI: 10.5771/9783845262321
  597. Orsi, Fabienne et al. (2003), Intellectual Property Rights, Anti-AIDS Policy and Generic Drugs: Lessons from the Brazilian Public Health Program, in: Jean-Paul Moatti et al. (Hrsg.), Economics of AIDS and Access to HIV/AIDS Care in Developing Countries: Issues and Challenges, Paris: ANRS, Collection Sciences Sociales et Sida, 109-135. Open Google Scholar DOI: 10.5771/9783845262321
  598. Ortiz, Michael (2013), Varieties of Innovation Systems: The Governance of Knowledge Transfer in Europe, Frankfurt: Campus Verlag. Open Google Scholar DOI: 10.5771/9783845262321
  599. OSDDI (2009), "Open Source Drug Discovery": An Open Collaborative Drug Discovery Model for Tuberculosis, Proposal Submitted before 'WHO Expert Working Group on R&D Financing', New Delhi. Open Google Scholar DOI: 10.5771/9783845262321
  600. OSEC (2010), Brazil's Pharmaceutical Industry: Opportunities for Swiss Suppliers, Zürich: Business Network Switzerland, 22. März. Open Google Scholar DOI: 10.5771/9783845262321
  601. Oyelaran-Oyeyinka, Banji (2005), Systems of Innovation and Underdevelopment: An Institutional Perspective, INTECH Discussion Paper 2005-1, Maastricht: United Nations University, Institute for New Technologies. Open Google Scholar DOI: 10.5771/9783845262321
  602. Oyelaran-Oyeyinka, Banji & Gehl Padmashree Sampath (2007), Learning Through Inter-organizational Interactions: Public Research Institutes in the Nigerian (Bio)pharmaceutical System of Innovation, European Journal of Development Research, 19(1), 174-193. Open Google Scholar DOI: 10.5771/9783845262321
  603. PAHO & USAID (2008), Health Systems and Services Profile: Brazil, Brasília: Pan American Health Organisation, USAID. Open Google Scholar DOI: 10.5771/9783845262321
  604. Paranhos, Julia & Lia Hasenclever (2011), O Relacionamento Entre Empresas Farmacêuticas e as Instituções de Ciência e Tecnologia no Brasil: Contribuições a Partir de Uma Pesquisa de Campo, Artigo em progresso a ser enviado para o XIV Congresso Latino-iberoamericano de Gestión Tecnológica, Lima, 19.-21. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  605. Parker, Rachel (2006), Small Business and Entrepreneurship in the Knowledge Economy: A Comparison of Australia and Sweden, New Political Economy, 11(2), 201-226. Open Google Scholar DOI: 10.5771/9783845262321
  606. Parto, Saeed, Tommaso Ciarli & Saurabh Arora (2006), Economic Growth, innovation systems and institutional change, 4th GLOBELICS International Conference: Innovation Systems for Competitiveness and Shared Prosperity in Developing Countries, Trivandrum, 04.-07. Oktober. Open Google Scholar DOI: 10.5771/9783845262321
  607. Patel, Parimal & Keith Pavitt (1994), Uneven (and Divergent) Technological Accumulation among Advanced Countries: Evidence and a Framework of Explanation, Industrial and Corporate Change, 3(3), 759-787. Open Google Scholar DOI: 10.5771/9783845262321
  608. Pavitt, Keith (1984), Sectoral patterns of technical change: Towards a taxonomy and a theory, Research Policy, 13, 343-373. Open Google Scholar DOI: 10.5771/9783845262321
  609. Pedersen, Jorge Dige (2008), Globalization, Development and the State. The Performance of India and Brazil since 1990, Basingstoke: Palgrave Macmillan. Open Google Scholar DOI: 10.5771/9783845262321
  610. Pefile, Sibongile (2005), Developing Innovative Capacity in South Africa to Meet Health Needs, in: Ingrid Hering (Hrsg.), Innovation in Developing Countries to Meet Health Needs: Experiences of China, Brazil, South Africa and India, Oxford: The Centre for Management of IP in Health R&D, 7-36. Open Google Scholar DOI: 10.5771/9783845262321
  611. Penchansky, Roy & J. William Thomas (1981), The Concept of Access: Definition and Relationship to Consumer Satisfaction, Medical Care, 19(2), 127-140. Open Google Scholar DOI: 10.5771/9783845262321
  612. Perez, Carlota (1985), Microelectronics, Long Waves and World Structural Change: New Perspectives for Developing Countries, World Development, 13(3), 441-463. Open Google Scholar DOI: 10.5771/9783845262321
  613. Perez, Carlota (2001), Technological Change and Opportunities for Development as a Moving Target, CEPAL Review, 75, 109-130. Open Google Scholar DOI: 10.5771/9783845262321
  614. Perez, Carlota & Luc Soete (1988), Catching up in technology: entry barriers and windows of opportunity, in: Giovanni Dosi et al. (Hrsg.), Technical Change and Economic Theory, London: Pinter, 458-479. Open Google Scholar DOI: 10.5771/9783845262321
  615. Peterson, M. J. (2010), Case Study: Access to HIV Treatments in Developing Countries - Appendix E: Understanding Drug Patents, in: International Dimensions of Ethics Education in Science and Engineering, Amherst: University of Massachusetts. Open Google Scholar DOI: 10.5771/9783845262321
  616. Pharmabiz.com (2012a), India, China most preferred CRAMS destinations, 10.05.12, <http://pharmabiz.com/PrintArticle.aspx?aid=68944&sid=0>. Open Google Scholar DOI: 10.5771/9783845262321
  617. Pharmabiz.com (2012b), Indian pharma companies obtains 144 ANDA approvals from US FDA in 2011, 02.01.12, <http://pharmabiz.com/NewsDetails. aspx?aid=66831 Open Google Scholar DOI: 10.5771/9783845262321
  618. &sid=2>. Open Google Scholar DOI: 10.5771/9783845262321
  619. Pharmalot (2008), Brazil Rejects Gilead Patent On HIV Drug, 09.03.08. Open Google Scholar DOI: 10.5771/9783845262321
  620. PharmaTimes (2008), Brazil rejects Gilead patent for HIV/AIDS drug Viread, 04.09.08. Open Google Scholar DOI: 10.5771/9783845262321
  621. PharmExec (2013), Drug Patents Under Fire in Brazil, PharmExecBlog, 04.06.13. Open Google Scholar DOI: 10.5771/9783845262321
  622. Philip, Kavita (2008), Producing Transnational Knowledge, Neoliberal Identities, and Technoscientific Practice in India, in: Beatriz da Costa & Kavita Philip (Hrsg.), Tactical Biopolitics: Art, Activism, and Technoscience, Cambridge: The MIT Press, 243-267. Open Google Scholar DOI: 10.5771/9783845262321
  623. Pietrobelli, Carlo & Roberta Rabellotti (2006), Clusters and Value Chains in Latin America: In Search of an Integrated Approach, in: Carlo Pietrobelli & Roberta Rabellotti (Hrsg.), Upgrading to Compete: Global Value Chains, Clusters, and SMEs in Latin America, Washington, D.C.: Inter-American Development Bank, 1-40. Open Google Scholar DOI: 10.5771/9783845262321
  624. Pietrobelli, Carlo & Roberta Rabellotti (2009), The Global Dimension of Innovation Systems: Linking Innovation Systems and Global Value Chains, in: Bengt-Åke Lundvall et al. (Hrsg.), Handbook of Innovation Systems and Developing Countries: Building Domestic Capabilities in a Global Setting, Cheltenham: Edward Elgar, 214-238. Open Google Scholar DOI: 10.5771/9783845262321
  625.   Open Google Scholar DOI: 10.5771/9783845262321
  626. Pietrobelli, Carlo & Roberta Rabellotti (2011), Global Value Chains Meet Innovation Systems: Are There Learning Opportunities for Developing Countries?, World Development, 39(7), 1261-1269. Open Google Scholar DOI: 10.5771/9783845262321
  627. PIJIP (2008), Timeline on Brazil's Cumpulsory Licensing, Program on Information Justice and Intellectual Property, Washington, D.C.: American University Washington College of Law. Open Google Scholar DOI: 10.5771/9783845262321
  628. Porter, Michael E. (1990), The Competitive Advantage of Nations, London: Macmillan. Open Google Scholar DOI: 10.5771/9783845262321
  629. Poth, Robert (1998), Faire WTO?, April 1998, <http://www.rpoth.at/pastwork/ Open Google Scholar DOI: 10.5771/9783845262321
  630. WTODISP1.shtml>. Open Google Scholar DOI: 10.5771/9783845262321
  631. Póvoa, Luciano Martins Costa, Roberto Mazzoleni & Thiago Caliari (2011), Innovation in the Brazilian Pharmaceutical Industry post-TRIPS, 9th GLOBELICS International Conference: Creativity, Innovation and Economic Development, Buenos Aires, 15.-17. November. Open Google Scholar DOI: 10.5771/9783845262321
  632. Powell, Walter W. (1990), Neither Market Nor Hierarchy: Network Forms of Organization, Research in Organizational Behavior, 12, 295-336. Open Google Scholar DOI: 10.5771/9783845262321
  633. Pradhan, Jaya Prakash (2008), Indian Direct Investment in Developing Countries: Emerging Trends and Development Impacts, MPRA Papers, No. 12323, Munich: University Library of Munich. Open Google Scholar DOI: 10.5771/9783845262321
  634. Przeworski, Adam & Henry Teune (1970), The Logic of Comparative Social Inquiry, New York: Wiley. Open Google Scholar DOI: 10.5771/9783845262321
  635. Public Citizen (2013), The Non-Discriminatory Nature of India’s National Pharmaceutical Pricing Policy: Clarification in Response to the Testimony of Ms. Linda Dempsey, House Energy and Commerce Committee Hearing on India’s Industrial Policy, Washington, D.C.: Public Citizen, <http://www.citizen.org/documents/India Open Google Scholar DOI: 10.5771/9783845262321
  636. %20hearing%20rebuttal%20FINAL.pdf>. Open Google Scholar DOI: 10.5771/9783845262321
  637. Ragin, Charles C. (1989), The Comparative Method: Moving Beyond Qualitative and Quantitative Strategies, Berkeley: University of California Press. Open Google Scholar DOI: 10.5771/9783845262321
  638. Rai, Rajnish Kumar (2009), Effect of the TRIPS-Mandated Intellectual Property Rights on Foreign Direct Investment in Developing Countries: A Case Study of the Indian Pharmaceutical Industry, The Journal of World Intellectual Property, 11(5/6), 404-431. Open Google Scholar DOI: 10.5771/9783845262321
  639. Raikes, Philip, Michael Friis Jensen & Stefano Ponte (2000), Global commodity chain analysis and the French filière approach: comparison and critique, Economy and Society, 29(3), 390-417. Open Google Scholar DOI: 10.5771/9783845262321
  640. Rajan, Ramkishen S. (2009), Monetary, Investment and Trade Issues in India, New York: Oxford University Press. Open Google Scholar DOI: 10.5771/9783845262321
  641. Ramani, Shyama V. (2002), Who is interested in biotech? R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms, Research Policy, 31(3), 381-398. Open Google Scholar DOI: 10.5771/9783845262321
  642. Ranbaxy Laboratories Limited (2002), Ranbaxy and Schwarz Pharma Sign a Deal to Develop New Drug to Treat Benign Prostate Hyperplasia, 27.06.02, Open Google Scholar DOI: 10.5771/9783845262321
  643. <http://www.ranbaxy.com/ranbaxy-and-schwarz-pharma-sign-a-deal-to-devel Open Google Scholar DOI: 10.5771/9783845262321
  644. op-new-drug-to-treat-benign-prostate-hyperplasia/>. Open Google Scholar DOI: 10.5771/9783845262321
  645. Ranbaxy Laboratories Limited (2008), Annual Report, Haryana, <http://www.ran baxy.com/wp-content/uploads/2012/ranbaxy_ar2008_3deluxe.pdf>. Open Google Scholar DOI: 10.5771/9783845262321
  646. Randeria, Shalini (2007), The State of Globalization: Legal Plurality, Overlapping Sovereignties and Ambiguous Alliances between Civil Society and the Cunning State in India, Theory, Culture & Society, 24(1), 1-33. Open Google Scholar DOI: 10.5771/9783845262321
  647. Rao, J. Manohar (2006), Globalization, Technology and Competition: Indian Pharmaceutical Industry in the Context of the WTO, Hyderabad: Media House Publications. Open Google Scholar DOI: 10.5771/9783845262321

Similar publications

from the series "Vergleichende Analyse politischer Systeme"
Cover of book: Zwischen Heimatschutz und Klimaleugnung
Monograph No access
Marius Fröhle
Zwischen Heimatschutz und Klimaleugnung
Cover of book: Auf dem Weg zum »Präsidialsystem alla Turca?«
Monograph No access
Mahir Tokatlı
Auf dem Weg zum »Präsidialsystem alla Turca?«
Cover of book: Don't Steal My Steel
Monograph No access
Ruth Beckmann
Don't Steal My Steel
Cover of book: Die Vermittlung von Reformen in Zeiten der Krise
Monograph No access
Pascal König
Die Vermittlung von Reformen in Zeiten der Krise
Cover of book: Wohlfahrtsstaatliche Strukturen und Parteieneffekte
Monograph No access
Frank Bandau
Wohlfahrtsstaatliche Strukturen und Parteieneffekte

Notice

This work is protected by copyright and may only be used in accordance with the provisions of the Terms of Use and License Agreement. Any use of the work beyond this is expressly prohibited and will be prosecuted.

Give feedback

We welcome your feedback on content and features. Your message helps us to continuously improve our service.

Rating
Attach images
or drag and drop
PNG or JPG (max. 3 MB)

Login

Forgotten your password?
Login via your Institution (SSO, Shibboleth, OpenAthens)
Don't have an account yet?
Register now

Cite publication

Download: RIS BibTex